"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID"
"CHEMBL1088913";"";"0";"349.48";"0";"3.58";"3527";"NCCCCN(Cc1nc2ccccc2[nH]1)C3CCCc4cccnc34";"PPB";"";"62.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL569720";"";"0";"353.37";"0";"2.53";"4384";"C[C@H](Nc1nc(Nc2cc(C)[nH]n2)c(C)nc1C#N)c3ncc(F)cn3";"PPB";"";"65.06";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1625921";"";"0";"320.48";"0";"3.6";"2831";"O=C(NC12CC3CC(CC(C3)C1)C2)OCCNC4CCCCC4";"PPB";"";"87.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1204759";"";"0";"415.86";"0";"3.22";"2172";"Cc1nn(c(NC(=O)NS(=O)(=O)c2ccc(Cl)cc2)c1C#N)c3ccccc3";"PPB";"";"98.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL239336";"";"0";"328.39";"0";"3.12";"3975";"CC1=C(C(NC(=O)N1)c2cccs2)C(=O)OCc3ccccc3";"PPB";"";"98.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL494161";"";"0";"474.3";"0";"2.35";"5144";"COc1cc(C(C)C)c(Oc2cnc(NC(CO)CO)nc2N)cc1I";"PPB";"";"97.2";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934269";"";"0";"460.52";"0";"4.03";"5461";"C[C@H](NC(=O)c1c(C)nn(CC(F)(F)F)c1NS(=O)(=O)c2ccc(C)cc2)C(C)(C)C";"PPB";"";"97.26";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1201335";"GLYCOPYRRONIUM";"4";"318.44";"0";"2.46";"3445";"C[N+]1(C)CCC(C1)OC(=O)C(O)(C2CCCC2)c3ccccc3";"PPB";"";"31.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158792";"";"0";"503.06";"2";"5.43";"3721";"Cc1cc(OC2CCN(CC3CCN(CC3)[C@@](C)(Cc4ccc(F)cc4)C(=O)O)CC2)ccc1Cl";"PPB";"";"73.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158790";"";"0";"537.5";"2";"6.08";"3561";"Cc1c(Cl)c(Cl)ccc1OC2CCN(CC3CCN(CC3)[C@@](C)(Cc4ccc(F)cc4)C(=O)O)CC2";"PPB";"";"92.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2338403";"";"0";"439.67";"0";"2.29";"5426";"CC(C)(C)S(=O)(=O)CCCN1CCN(CC(=O)NC23CC4CC(CC(C4)C2)C3)CC1";"PPB";"";"69.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1957848";"";"0";"344.8";"0";"2.03";"5157";"Clc1cccc(CN2C=CN3C(=O)C=C(N=C23)N4CCOCC4)c1";"PPB";"";"89.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158783";"";"0";"523.48";"2";"5.69";"3440";"Cc1c(Cl)ccc(OC2CCN(CC3CCN(CC3)[C@@H](Cc4ccc(F)cc4)C(=O)O)CC2)c1Cl";"PPB";"";"76.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL182997";"";"0";"381.9";"0";"1.81";"3569";"CC(C)(C)[C@@H](O)C(=O)N1CCC[C@H]1C(=O)NCc2cc(Cl)ccc2CN";"PPB";"";"50";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL604710";"Z160";"2";"460.62";"1";"6.14";"4533";"O=C(CC(c1ccccc1)c2ccccc2)N3CCN(CC3)C(c4ccccc4)c5ccccc5";"PPB";"";"50";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2316383";"";"0";"465.58";"0";"3.52";"4235";"C[S+]([O-])Cc1ccc(C(=O)Nc2cccnc2C(=O)NCC3CCOCC3)c4ccccc14";"PPB";"";"84.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1801504";"";"0";"367.36";"0";"3.26";"5672";"Fc1ccc2C(=CC(=O)Nc2c1F)Cn3c(nc4nccnc34)C5CCC5";"PPB";"";"84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL289330";"";"0";"371.28";"0";"2.68";"2567";"CCN1CCC[C@H]1CNC(=O)c2cc(Br)cc(OC)c2OC";"PPB";"";"29.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL945";"AMILORIDE";"4";"229.63";"0";"-1.08";"227";"NC(=N)NC(=O)c1nc(Cl)c(N)nc1N";"PPB";"";"31.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL578194";"";"0";"364.39";"0";"3.4";"4472";"C[C@H](Nc1nc(Nc2cc([nH]n2)C3CC3)cnc1C#N)c4ccc(F)cn4";"PPB";"";"93.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916274";"";"0";"452.58";"0";"4.35";"5022";"Cc1ccc(cc1)S(=O)(=O)Nc2c(C(=O)NC3CCCCC3)c(C)nn2c4ccccc4";"PPB";"";"97.86";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL436826";"";"0";"586.61";"2";"6.53";"3300";"CCOc1ccc(cc1)N2C(=O)c3ccccc3N=C2[C@@H](C)N(Cc4cccnc4)C(=O)Cc5ccc(cc5)C(F)(F)F";"PPB";"";"98.54";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2151176";"";"0";"435.53";"0";"4.25";"5385";"COc1cc(Nc2nc(COC3CCCC3)c4COCCc4n2)ccc1n5cnc(C)c5";"PPB";"";"97.95";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2181928";"";"0";"325.37";"0";"2.38";"5831";"C[C@@H]1CN([C@@H](CO1)c2ccccc2)c3ccc4OCC(=O)Nc4n3";"PPB";"";"90.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916278";"";"0";"454.55";"0";"3.2";"5078";"Cc1ccc(cc1)S(=O)(=O)Nc2c(C(=O)NC3CCOCC3)c(C)nn2c4ccccc4";"PPB";"";"91.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1689117";"";"0";"442.9";"0";"2.45";"3329";"OC(=O)COc1ccc(Cl)cc1CN2CCN(CC2)S(=O)(=O)c3ccc(F)cc3";"PPB";"";"91.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1782167";"";"0";"349.43";"0";"3.09";"4713";"Cc1ccc(cc1c2ccc(nc2)C(=O)NCC3CC3)C(=O)NC4CC4";"PPB";"";"91.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL456145";"";"0";"176.18";"0";"0.08";"5840";"C1Cc2[nH]nc(c2C1)c3nn[nH]n3";"PPB";"";"92.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL504813";"";"0";"408.45";"0";"3.02";"3972";"CC(C)Cc1c(C(=O)C(=O)N)c2c(OCC(=O)O)cccc2n1Cc3ccccc3";"PPB";"";"98.13";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL837";"7-ETHYL-10-HYDROXY-CAMPTOTHECIN";"0";"392.41";"0";"2.35";"3113";"CCc1c2CN3C(=O)C4=C(C=C3c2nc5ccc(O)cc15)[C@@](O)(CC)C(=O)OC4";"PPB";"";"90.52";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011112";"";"0";"485.03";"0";"3.6";"4071";"CC(C)N1Cc2c(NC(C)(C)Cc3ccc(Cl)cc3)nc(nc2C1=O)N4CCN(CC4)C(=O)C";"PPB";"";"96.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916283";"";"0";"454.6";"0";"4.45";"5086";"C[C@@H](NC(=O)c1c(C)nn(c1NS(=O)(=O)c2ccc(C)cc2)c3ccccc3)C(C)(C)C";"PPB";"";"96.26";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1389471";"";"0";"430.9";"1";"5.9";"4566";"Cc1cccc2cc(CN(Cc3occc3)C(=O)Nc4cccc(c4)C#N)c(Cl)nc12";"PPB";"";"99.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1486109";"";"0";"253.26";"0";"2.81";"1901";"COc1ccc(cc1)c2onc(n2)c3ccccn3";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL198362";"RIVAROXABAN";"4";"435.89";"0";"2.52";"2584";"Clc1ccc(s1)C(=O)NC[C@H]2CN(C(=O)O2)c3ccc(cc3)N4CCOCC4=O";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL260091";"";"0";"437.5";"0";"0.9";"5037";"C[C@@H](O)[C@H](NC(=O)c1ccc(cc1)C#Cc2ccc(CN3CCOCC3)cc2)C(=O)NO";"PPB";"";"93.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1770475";"";"0";"440.57";"1";"5.18";"3138";"CSCCC(NC(=O)c1ccccc1)c2nc3ccccc3n2Cc4ccc(cc4)C#N";"PPB";"";"97.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158771";"";"0";"516.47";"2";"5.12";"3159";"OC(=O)[C@H](Cc1ccc(cc1)C#N)N2CCC(CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4)CC2";"PPB";"";"90.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934422";"";"0";"462.62";"0";"3.82";"5462";"C[C@H](NC(=O)c1c(C)nn(C2CCOCC2)c1NS(=O)(=O)c3ccc(C)cc3)C(C)(C)C";"PPB";"";"83.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1938681";"";"0";"472.98";"1";"5.25";"5759";"Clc1ccc(cc1)c2oc(cc2)C(=O)N(Cc3ccccn3)c4ccc(cc4)N5CCNCC5";"PPB";"";"97.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL518924";"";"0";"349.48";"0";"3.58";"3570";"NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]3CCCc4cccnc34";"PPB";"";"75.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1963231";"";"0";"316.47";"0";"3.53";"3603";"CC(C1CCCC1)(C(=O)O[C@@H]2CC[N+](C)(C)C2)c3ccccc3";"PPB";"";"70.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934271";"";"0";"448.63";"0";"4.83";"5120";"CCC(CC)n1nc(C)c(C(=O)N[C@@H](C)C(C)(C)C)c1NS(=O)(=O)c2ccc(C)cc2";"PPB";"";"91.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179276";"";"0";"526.03";"2";"5.41";"5490";"CC(C)C[C@H](N1CCC[C@@H](C1)N2C=C(C)C(=O)NC2=O)c3ccc(C(=O)O)c(Oc4cccc(Cl)c4)c3";"PPB";"";"98.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL212432";"";"0";"451.92";"1";"0.09";"4421";"N\C(=N/C(=O)c1nc(Cl)c(N)nc1N)\NCCCCc2ccc(OCC(O)CO)cc2";"PPB";"";"68.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL515062";"";"0";"481.92";"0";"2.82";"3594";"CC(C)Oc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)nc(OC(CO)CO)c2Cl)n[nH]1";"PPB";"";"82.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2180033";"";"0";"324.82";"0";"3.8";"5411";"CC1=NC(N=C1N)(C2CC2)c3cccc(c3)c4cncc(Cl)c4";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158772";"";"0";"505.49";"2";"5.55";"2688";"Cc1ccccc1C[C@H](N2CCC(CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4)CC2)C(=O)O";"PPB";"";"88.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL15023";"TRIFLUPERIDOL";"4";"409.42";"0";"4.79";"1576";"OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3cccc(c3)C(F)(F)F";"PPB";"";"89.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2165054";"";"0";"475.55";"0";"1.92";"4230";"CO[C@H]1CN(CCN2C(=O)C=Cc3ccc(cc23)C#N)CC[C@H]1NCc4cc5OCCOc5cn4";"PPB";"";"26.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2151197";"PF-03654746";"2";"322.4";"0";"3.13";"5334";"CCNC(=O)[C@@H]1C[C@@](F)(C1)c2ccc(CN3CCCC3)c(F)c2";"PPB";"";"22.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1807823";"";"0";"447.63";"0";"2.87";"3615";"O[C@@H](CNCCSCCCNCCc1ccccc1)c2ccc(O)c3NC(=O)Sc23";"PPB";"";"55.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1429296";"";"0";"392.5";"0";"4.09";"2642";"COc1ccccc1CN2C(C(=O)NC3CCC(C)CC3)c4ccccc4C2=O";"PPB";"";"90.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2152524";"";"0";"320.48";"0";"4.66";"4767";"C1CCN(C1)[C@H]([C@@H](N2CCCC2)c3ccccc3)c4ccccc4";"PPB";"";"67.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL41547";"";"0";"896.11";"2";"1.32";"2789";"CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H]2CCCNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)[C@@H](CC5CCCCC5)NC(=O)[C@@H]6CCCN6C2=O";"PPB";"";"83.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL208825";"";"0";"422.32";"0";"2.22";"4973";"C[C@@H](CC(=O)OC(C)(C)C)NC(=O)C1=NOC(C1)C(O)(C(F)(F)F)C(F)(F)F";"PPB";"";"84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164741";"";"0";"461.52";"0";"1.26";"4211";"O[C@H]1CN(CCN2C(=O)C=Cc3ccc(cc23)C#N)CC[C@H]1NCc4cc5OCCOc5cn4";"PPB";"";"52.88";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL204997";"";"0";"318.34";"0";"2.61";"4198";"NC(=N)c1ccc2[nH]c(nc2c1)c3n[nH]c(c3O)c4ccccc4";"PPB";"";"88.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL551360";"";"0";"410.51";"0";"3.07";"4728";"OCC(CO)N1C=Cc2c(NC(=O)CC34CC5CC(CC(C5)C3)C4)cccc2C1=O";"PPB";"";"88.35";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL521096";"";"0";"437.52";"0";"3.68";"4112";"CCOc1cc2ncc(C(=O)N)c(Nc3ccc(C)cc3F)c2cc1N4CCN(C)CC4";"PPB";"";"84.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL319136";"";"0";"399.88";"0";"2.61";"236";"CN(C)C(=O)[C@H](O)[C@H](Cc1ccccc1)NC(=O)c2cc3cc(Cl)ccc3[nH]2";"PPB";"";"97.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL570273";"";"0";"430.82";"1";"5.86";"4453";"Cc1nc(ccc1C(=O)Nc2ccc(Cl)c(c2)c3nc4ccccc4[nH]3)C(F)(F)F";"PPB";"";"90.52";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1945034";"";"0";"464.59";"0";"2.89";"3876";"O[C@@H](CNCCc1ccc(CNCCc2ccccn2)cc1)c3ccc(O)c4NC(=O)Sc34";"PPB";"";"51.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2068817";"";"0";"348.4";"0";"4.44";"5778";"COc1ccccc1CN(C(=O)C)c2cnccc2Oc3ccccc3";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL516203";"";"0";"395.46";"0";"3.77";"4004";"Oc1cccc(OCC2CC2)c1c3cc([C@@H]4CCCNC4)c5COC(=O)Nc5n3";"PPB";"";"87.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2111112";"VERNAKALANT";"4";"349.47";"0";"2.64";"3759";"COc1ccc(CCO[C@@H]2CCCC[C@H]2N3CC[C@@H](O)C3)cc1OC";"PPB";"";"22.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL88";"CYCLOPHOSPHAMIDE";"4";"261.09";"0";"1.88";"88";"ClCCN(CCCl)P1(=O)NCCCO1";"PPB";"";"14.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2316389";"";"0";"464.52";"0";"2.8";"4308";"OCCOCCOc1ccc(NC(=O)c2ccnc3ccccc23)c(n1)C(=O)NCC4CCC4";"PPB";"";"97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL397983";"";"0";"603.6";"2";"5.81";"3365";"CCOc1ccc(cc1)N2C(=O)c3cccnc3N=C2[C@@H](C)N(Cc4cccnc4)C(=O)Cc5ccc(OC(F)(F)F)cc5";"PPB";"";"97.07";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1059";"PREGABALIN";"4";"159.23";"0";"1.08";"2606";"CC(C)C[C@H](CN)CC(=O)O";"PPB";"";"50";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1823817";"CE-224535";"2";"480.95";"0";"0.87";"3370";"COC[C@H](O)CN1C(=O)C=NN(C1=O)c2ccc(Cl)c(c2)C(=O)NCC3(O)CCCCCC3";"PPB";"";"52.3";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011115";"";"0";"492.5";"0";"3.02";"4123";"CC(C)N1Cc2c(NCc3ccc(OC(F)(F)F)cc3)nc(nc2C1=O)N4CCN(CC4)C(=O)C";"PPB";"";"84.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011118";"";"0";"506.53";"1";"3.58";"4253";"CC(C)N1Cc2c(N[C@H](C)c3ccc(OC(F)(F)F)cc3)nc(nc2C1=O)N4CCN(CC4)C(=O)C";"PPB";"";"89.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1441";"ETHIONAMIDE";"4";"166.25";"0";"1.28";"1539";"CCc1cc(ccn1)C(=S)N";"PPB";"";"45.98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL584260";"";"0";"504.01";"1";"2.38";"3036";"CC1=C(CC(=O)NCc2ccc(cc2)C(=N)N)C(=O)N(CC1)NS(=O)(=O)c3c(C)cccc3Cl";"PPB";"";"45.98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL652";"FLECAINIDE";"4";"414.35";"0";"3.44";"1623";"FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NCC2CCCCN2";"PPB";"";"46.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1900528";"TIOTROPIUM";"4";"392.52";"0";"2.35";"2996";"C[N+]1(C)[C@@H]2C[C@H](C[C@H]1[C@@H]3O[C@H]23)OC(=O)C(O)(c4cccs4)c5cccs5";"PPB";"";"47.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1381989";"";"0";"281.38";"0";"1.29";"1908";"CC1(C)CNC(=O)c2sc(nc2C1)N3CCOCC3";"PPB";"";"48.27";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1922267";"";"0";"421.51";"0";"4.12";"3437";"C[C@H]1[C@@H]2CN(CCN3CCOCC3)CC[C@H]2Cc4[nH]c5ccc(cc5c14)C(F)(F)F";"PPB";"";"96.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2031221";"";"0";"538.65";"1";"3.53";"489";"CN1CCN(CC1)c2ccc3N=CN(C(=O)c3c2)c4cc(NC(=O)c5cccc(c5)N6CCOCC6)ccc4C";"PPB";"";"89.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916085";"";"0";"452.58";"0";"4.39";"3667";"CN(C1CCCCC1)C(=O)c2cnn(c2NS(=O)(=O)c3ccc(C)cc3)c4ccccc4";"PPB";"";"98.13";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1088751";"PH-797804";"2";"477.31";"0";"4.43";"5418";"CNC(=O)c1ccc(C)c(c1)N2C(=CC(=C(Br)C2=O)OCc3ccc(F)cc3F)C";"PPB";"";"98.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1081913";"";"0";"360.41";"0";"3.05";"3973";"CC(C)(C)OC(=O)N1CCC(CC1)OCc2onc(n2)c3ccncc3";"PPB";"";"92.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934419";"";"0";"510.68";"1";"3.21";"5504";"C[C@H](NC(=O)c1c(C)nn(C2CCS(=O)(=O)CC2)c1NS(=O)(=O)c3ccc(C)cc3)C(C)(C)C";"PPB";"";"74.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1800659";"";"0";"485.65";"0";"3.71";"3492";"CCCCN(CCNCCc1ccc(O)c2NC(=O)Sc12)C(=O)CCOCCc3ccccc3";"PPB";"";"92.95";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011120";"";"0";"466.59";"0";"3.08";"4306";"CCOc1ccc(cc1)[C@@H](C)Nc2nc(nc3C(=O)N(Cc23)C(C)C)N4CCN(CC4)C(=O)C";"PPB";"";"78.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1774053";"";"0";"380.4";"0";"4.75";"3348";"C[C@H](Nc1nc(Nc2cc([nH]n2)C3CC3)c(F)cc1C#N)c4ccc(F)cc4";"PPB";"";"99.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL541944";"";"0";"569.58";"2";"5.19";"3435";"Fc1ccc(cc1)C(NC(=O)CN2CCN(Cc3ccn(c3)c4ccc(cn4)C(F)(F)F)CC2)c5ccc(F)cc5";"PPB";"";"99.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1761870";"";"0";"571.78";"1";"4.23";"5703";"C[C@@H]1CN(C[C@H](C)N1)C(=O)N[C@H](Cc2ccc(F)cc2)C(=O)N3CCC(CC3)(C4CCCCC4)C(=O)NC(C)(C)C";"PPB";"";"91.28";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916277";"";"0";"466.61";"0";"4.6";"5031";"CC1CCCCC1NC(=O)c2c(C)nn(c2NS(=O)(=O)c3ccc(C)cc3)c4ccccc4";"PPB";"";"97.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2029729";"";"0";"425.57";"0";"3.31";"4454";"CNC(=O)CCCN(C)C(=O)c1ccc2c(c1)c3C[C@@H](CCc3n2C)C4CCOCC4";"PPB";"";"98.54";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL398748";"";"0";"439.56";"1";"5.04";"3200";"COc1ccc2c(C)cc(N[C@H]3CC[C@@H](C3)NCc4cn(C)c5ccc(cc45)C#N)nc2c1";"PPB";"";"98.54";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1669170";"";"0";"525.61";"1";"4.23";"4131";"O=C(CN1CCOCC1)Nc2ccc(cc2c3ccccc3)c4cccc5C(=O)C=C(Oc45)N6CCOCC6";"PPB";"";"93.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL235789";"";"0";"401.98";"0";"3.69";"1583";"Clc1ccc(CN2CCNCC2)cc1C(=O)NCC34CC5CC(CC(C5)C3)C4";"PPB";"";"93.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2325014";"";"0";"500.36";"2";"5.15";"5734";"Nc1[nH]ncc1c2cc(Cl)ccc2Oc3cc(F)c(cc3Cl)S(=O)(=O)Nc4cscn4";"PPB";"";"99.45";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2326623";"";"0";"576.1";"1";"3.21";"5668";"COc1cccc2c1c(NS(=O)(=O)c3ccc(Cl)s3)nn2Cc4cccc(CNC(=O)[C@H]5COCCN5)c4";"PPB";"";"99.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1164729";"FEBUXOSTAT";"4";"316.38";"0";"3.72";"4028";"CC(C)COc1ccc(cc1C#N)c2nc(C)c(s2)C(=O)O";"PPB";"";"99.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1477";"CERIVASTATIN";"4";"459.56";"0";"4.88";"1116";"COCc1c(nc(C(C)C)c(\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)c1c2ccc(F)cc2)C(C)C";"PPB";"";"94.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2181247";"";"0";"484.37";"1";"5.85";"4427";"Fc1ccccc1c2ccnc3OCC(=O)N(Cc4cc(cc(c4)C(F)(F)F)C(F)(F)F)Cc23";"PPB";"";"99.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1359986";"";"0";"311.37";"0";"3.55";"2832";"Cc1ccc(NC(=O)Nc2nnc(s2)c3ccncc3)cc1";"PPB";"";"99.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1450473";"";"0";"418.5";"0";"1.14";"3111";"Cc1ccc(cc1)S(=O)(=O)NCCSc2nnnn2c3ccc(cc3)C(=O)N";"PPB";"";"81.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL522771";"";"0";"427.89";"0";"4.93";"5328";"Cc1ncsc1C(=O)N(CC2=CC(=O)Nc3c(F)cccc23)c4cccc(Cl)c4";"PPB";"";"91.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1088752";"LOSMAPIMOD";"3";"383.47";"0";"3.86";"5818";"Cc1c(F)cc(cc1c2ccc(cn2)C(=O)NCC(C)(C)C)C(=O)NC3CC3";"PPB";"";"91.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1944693";"";"0";"493.63";"0";"3.5";"3869";"COc1ccccc1CCNCc2cccc(CCNC[C@H](O)c3ccc(O)c4NC(=O)Sc34)c2";"PPB";"";"91.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158769";"";"0";"516.47";"2";"5.12";"3087";"OC(=O)[C@H](Cc1ccccc1C#N)N2CCC(CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4)CC2";"PPB";"";"77.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934266";"";"0";"406.55";"0";"3.8";"5112";"CCC(CC)NC(=O)c1c(C)nn(C(C)C)c1NS(=O)(=O)c2ccc(C)cc2";"PPB";"";"91.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158437";"";"0";"355.23";"0";"2.53";"5080";"Clc1cccc(CNC2=NC(=CC(=O)N2)N3CCOCC3)c1Cl";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1624529";"";"0";"416.36";"0";"1.89";"2836";"NC1C2CN(CC12)c3nc4N(C=C(C(=O)O)C(=O)c4cc3F)c5ccc(F)cc5F";"PPB";"";"91.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2338408";"";"0";"431.36";"0";"2.52";"5563";"CC(C)(C)NC(=O)NCCN1CCOC(CNC(=O)c2cc(Cl)cc(Cl)c2)C1";"PPB";"";"93.24";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL495575";"";"0";"448.49";"0";"2.57";"5397";"FC(F)(F)c1ccc(cc1S(=O)(=O)NC2CCNCC2)S(=O)(=O)c3ccccc3";"PPB";"";"77.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2180037";"";"0";"328.42";"0";"3.51";"5412";"CC#Cc1cncc(c1)c2cccc(c2)C3(N=C(C)C(=N3)N)C4CC4";"PPB";"";"93.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2312920";"";"0";"360.4";"0";"4.7";"5104";"CCCN(c1cccc(c1)C#N)P(=O)(c2ccccc2)c3ccccc3";"PPB";"";"93.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2337980";"";"0";"445.39";"0";"2.65";"5585";"CC(C)(C)NC(=O)NCCN1CCC(O)(CNC(=O)c2cc(Cl)cc(Cl)c2)CC1";"PPB";"";"76.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1818302";"";"0";"579.79";"1";"4.84";"4761";"CN(C)CCC1CCN(CC1)c2cc(C(=O)NC[C@@H]3CC[C@@H](CNC(=O)OC4CCOCC4)CC3)c5ccccc5n2";"PPB";"";"73.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1944694";"";"0";"493.63";"0";"3.5";"3844";"COc1ccccc1CCNCc2ccc(CCNC[C@H](O)c3ccc(O)c4NC(=O)Sc34)cc2";"PPB";"";"93.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2153581";"";"0";"458.42";"1";"5.08";"5726";"Fc1ccc(cc1C(F)(F)F)c2cc(CNC(=O)CCCc3ccc4cccnc4n3)on2";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL48966";"";"0";"262.32";"0";"3.22";"423";"C(Cc1nc2ccccc2[nH]1)c3nc4ccccc4[nH]3";"PPB";"";"79.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178934";"";"0";"325.41";"0";"2.9";"4680";"NC(=O)c1cncc(n1)c2ccc(cc2)[C@@H]3CC[C@@H](CCO)CC3";"PPB";"";"98.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL211177";"";"0";"422.32";"0";"2.22";"5291";"C[C@@H](CC(=O)OC(C)(C)C)NC(=O)C1=NO[C@H](C1)C(O)(C(F)(F)F)C(F)(F)F";"PPB";"";"81.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL403313";"";"0";"428.49";"0";"3.09";"5455";"CN(C)S(=O)(=O)NC(=O)CCCc1c([nH]c2ccc(cc12)C#N)c3ccc(F)cc3";"PPB";"";"99.58";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL7662";"";"0";"359.71";"0";"4.53";"5497";"COc1ccc(Cl)cc1C2(F)C(=O)Nc3cc(ccc23)C(F)(F)F";"PPB";"";"99.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916263";"";"0";"426.54";"0";"3.9";"5021";"CCC(CC)NC(=O)c1cn(nc1NS(=O)(=O)c2ccc(C)cc2)c3ccccc3";"PPB";"";"99.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2181926";"";"0";"381.43";"0";"3.49";"5861";"CCOC(=O)C1=C(C)NC(=C([C@H]1c2cccc3C(=O)C=C(C)Oc23)C(=O)C)C";"PPB";"";"99.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2152522";"";"0";"348.53";"1";"5.44";"4814";"C1CCN(CC1)[C@H]([C@@H](N2CCCCC2)c3ccccc3)c4ccccc4";"PPB";"";"68.13";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778623";"";"0";"431.43";"0";"3.87";"3035";"CCN(CC)S(=O)(=O)c1ccc(cc1)c2cc(ccc2OCC(=O)O)C(F)(F)F";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179275";"";"0";"526.03";"2";"5.41";"5489";"CC(C)C[C@@H](N1CCC[C@@H](C1)N2C=C(C)C(=O)NC2=O)c3ccc(C(=O)O)c(Oc4cccc(Cl)c4)c3";"PPB";"";"98.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2165257";"";"0";"256.26";"0";"3.38";"4948";"CC1=C(O)C(=C(OC1=O)c2oc3ccccc3c2)C";"PPB";"";"99.74";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2071507";"";"0";"408.81";"0";"4.87";"5527";"CC(C)C(NC(=O)c1cc(Cl)ccc1C(F)(F)F)C(=O)c2ccc(cc2)C#N";"PPB";"";"95.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164366";"";"0";"474.41";"0";"3.57";"5185";"Fc1cnc(CCN2C(C(=O)NCc3ccc(OC(F)(F)F)cc3)c4ccccc4C2=O)nc1";"PPB";"";"90.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2165192";"";"0";"350.42";"0";"2.76";"5107";"CC1CN(CCO1)C2=CC(=O)NC(=N2)NCc3cccc4ccccc34";"PPB";"";"97.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL550410";"";"0";"474.5";"1";"5.1";"3186";"Fc1cccc(CNC(=O)NC2CCN(Cc3ccn(c3)c4ccc(cc4)C(F)(F)F)CC2)c1";"PPB";"";"97.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2180027";"";"0";"371.44";"0";"3.49";"5448";"COc1ccc(cc1C)C2(N=C(C)C(=N2)N)c3cccc(c3)c4cncnc4";"PPB";"";"72.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1779512";"";"0";"480.95";"0";"0.87";"3582";"COC[C@@H](O)CN1C(=O)C=NN(C1=O)c2ccc(Cl)c(c2)C(=O)NCC3(O)CCCCCC3";"PPB";"";"39.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1689126";"";"0";"416.91";"0";"3.08";"3463";"C[C@H]1CN(Cc2cc(Cl)ccc2OCC(=O)O)CCN1C(=O)Cc3ccccc3";"PPB";"";"89.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL74355";"VOLINANSERIN";"3";"373.47";"0";"3.83";"4784";"COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC";"PPB";"";"34.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2071491";"";"0";"326.35";"0";"3.23";"4698";"CC(C)C(NC(=O)c1ccccc1)C(=O)c2ccc(cc2)[N+](=O)[O-]";"PPB";"";"93.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164364";"";"0";"456.42";"0";"3.43";"5083";"FC(F)(F)Oc1ccc(CNC(=O)C2N(CCc3ncccn3)C(=O)c4ccccc24)cc1";"PPB";"";"87.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2110579";"ANAMORELIN";"3";"546.72";"1";"2.72";"5621";"CN(C)N(C)C(=O)[C@@]1(Cc2ccccc2)CCCN(C1)C(=O)[C@@H](Cc3c[nH]c4ccccc34)NC(=O)C(C)(C)N";"PPB";"";"84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1027";"TIAGABINE";"4";"375.56";"1";"5.04";"1780";"Cc1ccsc1C(=CCCN2CCC[C@H](C2)C(=O)O)c3sccc3C";"PPB";"";"91.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1671897";"";"0";"479.58";"0";"4.59";"3135";"COc1ccc(CC(=O)NCc2ccccc2c3ccccc3C(=O)NCCc4cccnc4)cc1";"PPB";"";"91.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL378997";"";"0";"360.44";"0";"3.82";"4200";"COC(=O)N[C@@H](C)C#Cc1cnc(Oc2ccc(OC(C)C)cc2)s1";"PPB";"";"99.49";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL594671";"";"0";"294.81";"0";"4.17";"5238";"CC(C)[C@H](C(=O)Nc1nccs1)c2ccc(Cl)cc2";"PPB";"";"98.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2337981";"";"0";"459.42";"0";"2.9";"5582";"CC(C)(C)NC(=O)NCCN1CCC(CO)(CNC(=O)c2cc(Cl)cc(Cl)c2)CC1";"PPB";"";"79.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL493677";"";"0";"389.34";"0";"4.82";"5254";"CC(C)(C)CCN1CC[C@H](CNC(=O)c2cc(Cl)cc(Cl)c2)[C@H](F)C1";"PPB";"";"91.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL282479";"";"0";"343.69";"0";"3.25";"3695";"Oc1ccc(Cl)cc1C2(O)C(=O)Nc3cc(ccc23)C(F)(F)F";"PPB";"";"98.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL376632";"";"0";"420.47";"0";"2.03";"2171";"Cc1cc(nc(n1)n2ccnc2)N3CCC[C@@H]3C(=O)NCCc4ccc5OCOc5c4";"PPB";"";"78.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL521509";"";"0";"406.45";"0";"3.07";"4170";"O=C(NC1CC1)C2=CN(c3cccc(c3)C#Cc4cccnc4)c5ncccc5C2=O";"PPB";"";"99.18";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178579";"ELUBRIXIN";"2";"463.32";"0";"3.08";"3413";"Oc1c(NC(=O)Nc2cccc(F)c2Cl)ccc(Cl)c1S(=O)(=O)N3CCNCC3";"PPB";"";"98.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1818295";"";"0";"524.71";"1";"4.89";"4471";"CC(C)(C)OC(=O)NC[C@@H]1CC[C@@H](CNC(=O)c2cc(nc3ccccc23)N4CCC(CCO)CC4)CC1";"PPB";"";"99.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147303";"";"0";"482.41";"0";"4.15";"5568";"COc1ncc(cn1)c2ccccc2C(F)(F)CNC(=O)c3ccc(COCC(F)(F)F)nc3";"PPB";"";"87.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179269";"";"0";"483.95";"0";"4.39";"5381";"C[C@@H](N1CCC[C@@H](C1)N2C=C(C)C(=O)NC2=O)c3ccc(C(=O)O)c(Oc4cccc(Cl)c4)c3";"PPB";"";"97.07";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL165330";"";"0";"382.36";"0";"0.96";"2250";"CC(O)(C(=O)Nc1ccc(cc1)S(=O)(=O)N2CCOCC2)C(F)(F)F";"PPB";"";"84.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2313226";"";"0";"385.41";"0";"4.41";"4887";"O=P(N(Cc1ccccn1)c2cccnc2)(c3ccccc3)c4ccccc4";"PPB";"";"85.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL113";"CAFFEINE";"4";"194.19";"0";"-1.03";"86";"CN1C(=O)N(C)c2ncn(C)c2C1=O";"PPB";"";"13.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2071498";"";"0";"306.37";"0";"3.2";"4724";"CC(C)C(NC(=O)c1ccccc1)C(=O)c2ccc(cc2)C#N";"PPB";"";"87.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL262273";"";"0";"366.36";"0";"1.72";"2251";"CC(O)(C(=O)Nc1ccc(cc1)S(=O)(=O)N2CCCC2)C(F)(F)F";"PPB";"";"88.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL402146";"";"0";"268.65";"0";"3.27";"4277";"Fc1ccc(cc1F)C(=O)Nc2ccc(Cl)nc2";"PPB";"";"88.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916024";"";"0";"420.45";"0";"2.08";"5615";"Nc1nc(nc(N)c1N2CCOCC2)c3nn(Cc4ccccc4F)c5ncccc35";"PPB";"";"88.35";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2337982";"";"0";"389.58";"0";"2.51";"5414";"O=C(CN1CCN(CCC2CCOCC2)CC1)NC34CC5CC(CC(C5)C3)C4";"PPB";"";"60.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL223402";"";"0";"388.4";"0";"3.76";"4790";"Fc1ccccc1NC(=O)N[C@H]2N=C(c3ccccc3)c4ccccc4NC2=O";"PPB";"";"97.26";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934416";"";"0";"450.61";"0";"3.67";"5487";"COCC(C)n1nc(C)c(C(=O)N[C@@H](C)C(C)(C)C)c1NS(=O)(=O)c2ccc(C)cc2";"PPB";"";"86.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL502347";"";"0";"295.39";"0";"1.75";"5318";"N[C@@H]1CCN(C1)c2nc(N)nc3c2CCCc4ccccc34";"PPB";"";"56.3";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2316109";"";"0";"435.55";"0";"3.9";"4401";"C[S+]([O-])Cc1ccc(C(=O)Nc2cccnc2C(=O)NCC3CCC3)c4ccccc14";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1807820";"";"0";"498.67";"0";"4.45";"3500";"O[C@@H](CNCCCSCCOCCc1cccc2ccccc12)c3ccc(O)c4NC(=O)Sc34";"PPB";"";"99.18";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL562551";"";"0";"262.7";"0";"3";"3493";"COc1cc(NC(=O)c2ccccn2)ccc1Cl";"PPB";"";"95.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1071";"OXAPROZIN";"4";"293.32";"0";"4.03";"102";"OC(=O)CCc1oc(c2ccccc2)c(n1)c3ccccc3";"PPB";"";"99.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1938680";"";"0";"381.86";"0";"4.26";"5757";"Clc1ccc(cc1)c2oc(cc2)C(=O)Nc3ccc(cc3)N4CCNCC4";"PPB";"";"99.45";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778639";"";"0";"402.39";"0";"3.94";"2461";"CCS(=O)(=O)c1ccc(c(C)c1)c2cc(ccc2OCC(=O)O)C(F)(F)F";"PPB";"";"92.95";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916286";"";"0";"446.62";"0";"4.42";"5141";"C[C@H](NC(=O)c1c(C)nn(c1NS(=O)(=O)C2CCCCC2)c3ccccc3)C(C)(C)C";"PPB";"";"98.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1096896";"UK432097";"2";"777.89";"3";"1.92";"4256";"CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(NCC(c4ccccc4)c5ccccc5)nc(nc23)C(=O)NCCNC(=O)NC6CCN(CC6)c7ccccn7";"PPB";"";"98.58";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL321758";"";"0";"327.42";"0";"2.8";"4624";"C[C@H]([C@H](O)c1ccc(O)cc1)N2CCC(O)(CC2)c3ccccc3";"PPB";"";"39.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2057372";"";"0";"516.58";"1";"0.85";"5664";"CC(C)(C)NS(=O)(=O)c1cncc(c1)c2ccc3nc(NC(=O)NCC(=O)N4CCOCC4)nn3c2";"PPB";"";"46.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1077896";"ROPIVACAINE";"4";"274.41";"0";"3.51";"1782";"CCCN1CCCC[C@H]1C(=O)Nc2c(C)cccc2C";"PPB";"";"48.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL402501";"";"0";"492.66";"0";"3.77";"4406";"C[C@H](Cc1cccc(CC(=O)NC23CC4CC(CC(C4)C2)C3)c1)NC[C@H](O)c5ccc(O)c(CO)c5";"PPB";"";"86.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1917440";"";"0";"409.9";"1";"5.3";"2686";"Cc1c(Sc2ccc(Cl)cc2)c3c(cccc3n1CC(=O)O)c4cnccn4";"PPB";"";"97.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2069424";"";"0";"444.41";"0";"3.52";"4657";"Cc1ncc(cn1)c2cccc3OC[C@H](Cc23)NC(=O)c4ccc(OCC(F)(F)F)nc4";"PPB";"";"92.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1668935";"";"0";"355.5";"0";"1.68";"5270";"CS(=O)(=O)N1CCC(CC1)NC(=O)NC23CC4CC(CC(C4)C2)C3";"PPB";"";"73.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1865796";"";"0";"293.17";"0";"3.18";"4334";"Cc1ccccc1Nc2nc(N)nc(C)c2Br";"PPB";"";"92.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2338404";"";"0";"454.68";"0";"1.65";"5546";"CC(C)(C)CS(=O)(=O)NCCN1CCN(CC(=O)NC23CC4CC(CC(C4)C2)C3)CC1";"PPB";"";"87.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL570002";"";"0";"339.34";"0";"2.23";"4348";"C[C@H](Nc1nc(Nc2cc(C)[nH]n2)cnc1C#N)c3ncc(F)cn3";"PPB";"";"62.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916082";"";"0";"426.54";"0";"3.9";"3668";"CCC(CC)NC(=O)c1cnn(c1NS(=O)(=O)c2ccc(C)cc2)c3ccccc3";"PPB";"";"97.66";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2030560";"";"0";"237.26";"0";"2.38";"507";"Nc1nc2ccc(cc2[nH]1)C(=O)c3ccccc3";"PPB";"";"92.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916285";"";"0";"539.7";"1";"3.98";"5138";"C[C@H](NC(=O)c1c(C)nn(c1NS(=O)(=O)c2cccc(CN3CCOCC3)c2)c4ccccc4)C(C)(C)C";"PPB";"";"84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL93124";"";"0";"256.33";"0";"3.71";"3214";"CNc1ccc(cc1)c2nc3ccc(O)cc3s2";"PPB";"";"98.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL13817";"IBUTAMOREN";"2";"528.68";"1";"1.77";"2595";"CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N2CCC3(CC2)CN(c4ccccc34)S(=O)(=O)C";"PPB";"";"74.69";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL560219";"";"0";"424.81";"0";"3.85";"4738";"OCCN1C=Cc2c(NC(=O)Cc3ccc(Cl)c(c3)C(F)(F)F)cccc2C1=O";"PPB";"";"92.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL715";"OLANZAPINE";"4";"312.44";"0";"3.44";"823";"CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24";"PPB";"";"87.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL55076";"MYRIOCIN";"0";"401.54";"0";"2.31";"4080";"CCCCCCC(=O)CCCCCC\C=C\C[C@@H](O)[C@H](O)[C@@](N)(CO)C(=O)O";"PPB";"";"97.2";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL556680";"";"0";"419.57";"0";"4.3";"4756";"O=C(CC12CC3CC(CC(C3)C1)C2)Nc4cccc5C(=O)N(C[C@H]6CCCN6)C=Cc45";"PPB";"";"84.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2087433";"";"0";"495.69";"0";"2.53";"5767";"COc1cc(C)c(c(C)c1)S(=O)(=O)N(C)CCOCC(=O)N2CCC(CC2)C3CCN(C)CC3";"PPB";"";"48.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL83597";"";"0";"351.41";"0";"3.85";"1846";"CN1CCC[C@@H]1Cc2c[nH]c3ccc(Nc4ncccc4[N+](=O)[O-])cc23";"PPB";"";"61.31";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL210884";"";"0";"315.33";"0";"0.78";"2289";"COCCOc1nc(N)c2NC(=O)N(Cc3ccccc3)c2n1";"PPB";"";"62.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL464081";"";"0";"445.51";"0";"2.95";"2943";"CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N3CCN(CC3)c4ccc(cn4)C(F)(F)F)C(=O)C2";"PPB";"";"98.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL192307";"";"0";"296.42";"0";"4.17";"2319";"CCCCc1nc2c(N)nc3ccccc3c2n1CC(C)C";"PPB";"";"96.93";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1112";"ARIPIPRAZOLE";"4";"448.39";"0";"4.86";"3196";"Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl";"PPB";"";"99.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1263";"SALMETEROL";"4";"415.57";"0";"4.11";"1788";"OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc2ccccc2";"PPB";"";"92.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1724416";"";"0";"302.36";"0";"3.25";"1541";"Cc1ccc(cc1)S(=O)(=O)Nc2ccc3nc(C)oc3c2";"PPB";"";"94.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2036958";"";"0";"276.29";"0";"1.29";"5901";"CC1(CCCC2=CC(=O)OC3=C2C(=O)NC(=O)N3)CC1";"PPB";"";"98.51";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1412533";"";"0";"309.76";"0";"4.11";"1657";"Clc1ccc(OCc2cn3ccccc3n2)c4ncccc14";"PPB";"";"99.3";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1484";"NICARDIPINE";"4";"479.53";"0";"3.68";"833";"COC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OCCN(C)Cc3ccccc3)C";"PPB";"";"99.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL30054";"";"0";"452.82";"0";"2.35";"2588";"Fc1cccnc1CNC(=O)CN2C(=CN=C(NCC(F)(F)c3ccccn3)C2=O)Cl";"PPB";"";"79.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2204344";"";"0";"425.5";"";"";"4861";"O[Si]1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3cccc(c3)C(F)(F)F";"PPB";"";"95.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2137199";"";"0";"527.48";"2";"5.52";"5825";"OC(c1ccc(c(F)c1)c2ccc(CN3CCN(Cc4ccncc4)CC3)cc2)(C(F)(F)F)C(F)(F)F";"PPB";"";"99.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL571";"KETOPROFEN";"4";"254.29";"0";"3.11";"735";"CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2";"PPB";"";"99.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178952";"";"0";"339.4";"0";"2.99";"4436";"NC(=O)c1cncc(n1)c2ccc(cc2)[C@@H]3CC[C@@H](CC(=O)O)CC3";"PPB";"";"99.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778642";"";"0";"375.23";"0";"3.53";"3015";"CS(=O)(=O)c1ccc(c(Cl)c1)c2cc(Cl)ccc2OCC(=O)O";"PPB";"";"96.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2325622";"";"0";"538.99";"1";"4.41";"5659";"CN1CC(C1)n2nccc2c3cc(Cl)ccc3Oc4cc(F)c(cc4F)S(=O)(=O)Nc5ncns5";"PPB";"";"96.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL782";"TOLBUTAMIDE";"4";"270.35";"0";"1.78";"122";"CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1";"PPB";"";"97.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178931";"";"0";"395.5";"0";"4.42";"4642";"CC(C)c1nc(C)c(nc1c2ccc(cc2)[C@@H]3CC[C@@H](CC(=O)O)CC3)C(=O)N";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2324342";"";"0";"473.58";"0";"3.23";"4539";"CC(C)N1Cc2c(N[C@H](C)c3cnc4ccccc4c3)nc(nc2C1=O)N5CCN(CC5)C(=O)C";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2152918";"";"0";"453.38";"0";"4.63";"5721";"CO[C@@H]1CC[C@@]2(CC1)Cc3ccc(cc3C24N=C(C)C(=N4)N)c5cncc(Br)c5";"PPB";"";"93.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147317";"";"0";"500.4";"1";"4.29";"5594";"COc1cnc(cn1)c2cccc(F)c2C(F)(F)CNC(=O)c3ccc(COCC(F)(F)F)nc3";"PPB";"";"95.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL510780";"";"0";"263.34";"0";"4.05";"5565";"C1C[C@@H](Nc2nc3ccccc3[nH]2)c4ccccc4C1";"PPB";"";"95.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL457393";"";"0";"357.37";"0";"3.67";"3558";"C[C@H](Nc1ncc(F)c(Nc2cc([nH]n2)C3CC3)n1)c4ccc(F)cn4";"PPB";"";"96.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL217899";"TOFIMILAST";"2";"339.47";"0";"4.1";"3428";"CCc1nn(C2CCCC2)c3c1CCn4c(nnc34)c5cccs5";"PPB";"";"95.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1257491";"";"0";"439.38";"1";"5.76";"5156";"Oc1ccc2cc(CNCCc3ccc(Br)cc3)c(nc2c1)c4ccsc4";"PPB";"";"99.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL222659";"";"0";"491.6";"1";"6.03";"2736";"O=C(Nc1ccccn1)c2ccc3[nH]c(nc3c2)c4ccc(NC(=O)C56CC7CC(CC(C7)C5)C6)cc4";"PPB";"";"99.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2337977";"";"0";"387.31";"0";"2.51";"5575";"CC(C)(C)NC(=O)NCCN1CC(C1)NC(=O)c2cc(Cl)cc(Cl)c2";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL95308";"3,5-DIHYDROXYBENZOIC ACID";"0";"154.12";"0";"0.8";"890";"OC(=O)c1cc(O)cc(O)c1";"PPB";"";"17.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1684954";"";"0";"378.39";"0";"4.32";"5384";"C[C@@H](NC(=O)Cc1ccc(cc1)C2CC2)c3ccc(OCC(F)(F)F)cn3";"PPB";"";"99.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL257178";"";"0";"453.42";"0";"4.13";"5618";"Fc1ccc(cc1)c2[nH]c3ccc(cc3c2CCCC(=O)NS(=O)(=O)C(F)(F)F)C#N";"PPB";"";"93.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2010836";"";"0";"458.49";"0";"3.35";"4711";"CN(C1CCN(Cc2ccc(cc2)C(F)(F)F)CC1)C(=O)Cc3ccc(cc3)n4cnnn4";"PPB";"";"93.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL422649";"";"0";"373.35";"0";"2.77";"2353";"CC(O)(C(=O)Nc1cccc(c1)S(=O)(=O)c2ccccc2)C(F)(F)F";"PPB";"";"94.06";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL254497";"";"0";"553.59";"2";"5.25";"5110";"CC(C)(C)OC(=O)N[C@H](Cc1ccccc1C(F)(F)F)C(=O)NCc2nc3cccnc3n2Cc4ccccc4";"PPB";"";"99.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916273";"";"0";"412.52";"0";"3.43";"5020";"CC(C)NC(=O)c1c(C)nn(c1NS(=O)(=O)c2ccc(C)cc2)c3ccccc3";"PPB";"";"94.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1818296";"";"0";"551.78";"2";"5.46";"4535";"CN(C)CCC1CCN(CC1)c2cc(C(=O)NC[C@@H]3CC[C@@H](CNC(=O)OC(C)(C)C)CC3)c4ccccc4n2";"PPB";"";"96";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1609158";"";"0";"315.76";"0";"4.28";"3170";"CCCC(=O)Nc1ccc(Cl)c(c1)c2oc3cccnc3n2";"PPB";"";"96.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL497963";"";"0";"453.61";"0";"4.25";"4997";"Cc1ccc2c(OCCN3CCC(Cc4cccc(NS(=O)(=O)C)c4)CC3)cccc2n1";"PPB";"";"94.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158390";"";"0";"286.34";"0";"1.22";"4992";"O=C1NC(=NC(=C1)N2CCOCC2)NCc3ccccc3";"PPB";"";"81.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178935";"";"0";"366.47";"0";"3.01";"4701";"Cc1nc(C)c(nc1C(=O)N)c2ccc(cc2)[C@@H]3CC[C@@H](CC(=O)N)CC3";"PPB";"";"94.44";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2151325";"";"0";"401.38";"0";"2.55";"4377";"CCOc1cc(Nc2nc3c(cc2F)ncn3[C@@H](CO)c4ccc(F)cn4)n[nH]1";"PPB";"";"83.04";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2151147";"";"0";"430.43";"0";"4.21";"5564";"C[C@@H](NC(=O)Cc1ccc(cc1)c2nccnc2C)c3ccc(OCC(F)(F)F)cn3";"PPB";"";"83.04";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2325601";"";"0";"533.92";"2";"5.52";"5711";"Nc1n[nH]cc1c2cc(ccc2Oc3cc(F)c(cc3Cl)S(=O)(=O)Nc4cscn4)C(F)(F)F";"PPB";"";"99.28";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL456390";"";"0";"274.32";"0";"3.79";"5287";"O=C1CCc2cc(ccc2N1)c3cncc4ccccc34";"PPB";"";"96.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1743245";"";"0";"333.4";"0";"4.7";"1347";"Cc1ccccc1\N=N\c2ccc(NC(=O)c3ccnn3C)c(C)c2";"PPB";"";"99.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2181753";"AM-211";"1";"500.52";"2";"5.74";"5783";"CCN(Cc1cc(ccc1c2cc(CC(=O)O)ccc2OC)C(F)(F)F)C(=O)NCc3ccccc3";"PPB";"";"98.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1650726";"";"0";"349.76";"0";"2.97";"4435";"C[C@H](Oc1ncc(Cl)c(Nc2cc(C)[nH]n2)n1)c3ncc(F)cn3";"PPB";"";"66.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL560993";"OC000459";"2";"348.38";"0";"4.31";"4409";"Cc1c(Cc2ccc3ccccc3n2)c4cc(F)ccc4n1CC(=O)O";"PPB";"";"99.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1454310";"";"0";"355.18";"0";"3.14";"1902";"Cc1cc(I)cc2C3C=CCC3C(Nc12)C(=O)O";"PPB";"";"99.3";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778637";"";"0";"408.78";"0";"3.89";"3014";"CS(=O)(=O)c1ccc(c(Cl)c1)c2cc(ccc2OCC(=O)O)C(F)(F)F";"PPB";"";"95.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916266";"";"0";"427.53";"0";"3.29";"4971";"CCC(CC)NC(=O)c1cnn(c1NS(=O)(=O)c2ccc(C)cc2)c3ccccn3";"PPB";"";"95.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2071592";"";"0";"329.83";"0";"4.37";"4922";"CC(C)(C)C(NC(=O)c1ccccc1)C(=O)c2ccc(Cl)cc2";"PPB";"";"99.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1835918";"";"0";"337.38";"0";"2.66";"5060";"Cc1onc(n1)c2ccc(OCC3CN(C3)c4ccc(C)nn4)cc2";"PPB";"";"95.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934413";"";"0";"432.59";"0";"4.19";"5496";"C[C@H](NC(=O)c1c(C)nn(C2CCC2)c1NS(=O)(=O)c3ccc(C)cc3)C(C)(C)C";"PPB";"";"97.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2324776";"";"0";"531.9";"2";"5.4";"5684";"Fc1cc(Oc2ccc(cc2c3ccnnc3)C(F)(F)F)c(Cl)cc1S(=O)(=O)Nc4nncs4";"PPB";"";"98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1364767";"";"0";"255.36";"0";"3.95";"1904";"Cc1nn(C2CCCCC2)c(N)c1c3ccccc3";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL12";"DIAZEPAM";"4";"284.75";"0";"3.15";"370";"CN1C(=O)CN=C(c2ccccc2)c3cc(Cl)ccc13";"PPB";"";"87.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011109";"";"0";"471.01";"0";"3.38";"4075";"CC(C)N1Cc2c(NCC(C)c3ccc(Cl)cc3)nc(nc2C1=O)N4CCN(CC4)C(=O)C";"PPB";"";"85.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1290184";"";"0";"362.52";"0";"4.51";"2146";"Cc1cccc(CN2CCC3(CC2)CCN(CC3)C(=O)c4ccccc4)c1";"PPB";"";"54.02";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934426";"";"0";"488.65";"0";"4.39";"5516";"C[C@H](NC(=O)c1c(C)nn(C2CCOCC2)c1NS(=O)(=O)c3ccc(cc3)C4CC4)C(C)(C)C";"PPB";"";"89.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL520278";"";"0";"457.94";"0";"4.02";"4096";"CCOc1cc2ncc(C(=O)N)c(Nc3cccc(Cl)c3F)c2cc1N4CCN(C)CC4";"PPB";"";"86.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1818299";"";"0";"539.72";"1";"4.06";"4907";"CN(C)CCOC1CN(C1)c2cc(C(=O)NC[C@@H]3CC[C@@H](CNC(=O)OC(C)(C)C)CC3)c4ccccc4n2";"PPB";"";"87.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178937";"";"0";"452.56";"0";"3.5";"4700";"Cc1nc(C)c(nc1C(=O)N)c2ccc(cc2)[C@@H]3CC[C@@H](CC(=O)NC(C)(C)C(=O)O)CC3";"PPB";"";"97.49";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1290183";"";"0";"382.94";"0";"4.86";"2156";"Clc1cccc(CN2CCC3(CC2)CCN(CC3)C(=O)c4ccccc4)c1";"PPB";"";"83.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL242693";"";"0";"311.34";"0";"3.03";"5744";"C[C@@H](Oc1ccccc1c2cccc(c2)[N+](=O)[O-])C3=NCCN3";"PPB";"";"59.66";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1499";"";"0";"360.45";"0";"1.99";"2804";"C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)CC(=O)[C@H]23";"PPB";"";"60.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL222333";"";"0";"376.4";"0";"3.97";"3747";"CCNC(=O)Nc1nc2cc(cc(c3ncccc3F)c2[nH]1)c4cccnc4";"PPB";"";"97.2";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL507674";"CEFOPERAZONE";"4";"645.68";"2";"-1.11";"3165";"CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SCC(=C(N3C2=O)C(=O)O)CSc4nnnn4C)c5ccc(O)cc5)C(=O)C1=O";"PPB";"";"69.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2325642";"";"0";"524.96";"1";"4.07";"5654";"Fc1cc(c(F)cc1Oc2ccc(Cl)cc2c3ccnn3C4CNC4)S(=O)(=O)Nc5ncns5";"PPB";"";"94.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1201753";"PITAVASTATIN";"4";"421.47";"0";"4.52";"1191";"O[C@H](C[C@H](O)\C=C\c1c(nc2ccccc2c1c3ccc(F)cc3)C4CC4)CC(=O)O";"PPB";"";"99.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2180024";"";"0";"344.39";"0";"3.92";"5202";"CC1=NC(N=C1N)(c2ccc(F)cc2)c3cccc(c3)c4cccnc4";"PPB";"";"91.28";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1852508";"";"0";"434.97";"0";"2.65";"3703";"Cc1cc(nn1C[C@H](O)CN)c2ccc(Cl)c(c2)C(=O)NCC3(O)CCCCCC3";"PPB";"";"69.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2337984";"";"0";"390.57";"0";"1.6";"5440";"CC(C)(C)NC(=O)CN1CCN(CC(=O)NC23CC4CC(CC(C4)C2)C3)CC1";"PPB";"";"69.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916272";"";"0";"440.57";"0";"4.21";"4995";"CCC(CC)NC(=O)c1c(C)nn(c1NS(=O)(=O)c2ccc(C)cc2)c3ccccc3";"PPB";"";"97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164566";"";"0";"378.35";"0";"3.97";"5494";"CCN(CCO)C(=O)c1oc2cccnc2c1c3cccc(c3)C(F)(F)F";"PPB";"";"86.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL552513";"";"0";"449.4";"0";"2.85";"4777";"O[C@@H]1CNC[C@H]1N2C=Cc3c(NC(=O)Cc4ccc(F)c(c4)C(F)(F)F)cccc3C2=O";"PPB";"";"90.52";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2010831";"";"0";"468.54";"0";"3.77";"4654";"CN(C1CCN(Cc2ccc(cc2)C(F)(F)F)CC1)C(=O)Cc3ccc(cc3)S(=O)(=O)C";"PPB";"";"84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL576257";"";"0";"338.35";"0";"2.83";"4386";"C[C@H](Nc1nc(Nc2cc(C)[nH]n2)cnc1C#N)c3ccc(F)cn3";"PPB";"";"84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1962896";"";"0";"542.1";"1";"3.75";"5612";"COc1ccc(CCC[N+](C)(CCCc2ccc(OC)cc2)CCNC(=O)c3nc(Cl)c(N)nc3N)cc1";"PPB";"";"84.3";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1924034";"";"0";"305.44";"0";"2.25";"4313";"CN(C)C(C)(C(=O)OC1CC[N+](C)(C)CC1)c2ccccc2";"PPB";"";"54.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL226646";"";"0";"389.82";"0";"3.68";"4577";"Cc1oc(nn1)c2ccc(nn2)N3CCC(CC3)Oc4cc(F)ccc4Cl";"PPB";"";"99.18";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1089518";"";"0";"371.4";"0";"1.56";"3195";"CCCCOc1nc(N)c2NC(=O)N(Cc3cccc(CC(=O)O)c3)c2n1";"PPB";"";"95.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481212";"";"0";"437.52";"0";"3.68";"4109";"CCOc1cc2ncc(C(=O)N)c(Nc3cc(C)ccc3F)c2cc1N4CCN(C)CC4";"PPB";"";"89.27";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778636";"";"0";"287.7";"0";"3.34";"3175";"OC(=O)COc1ccc(Cl)cc1c2cccc(c2)C#N";"PPB";"";"96.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2030567";"";"0";"511.69";"1";"3.98";"4810";"CCNC(=O)Nc1sc2ccccc2c1C(=O)N3CCC(CC3)N4CCCC5(CCN(CC)C5=O)C4";"PPB";"";"83.04";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1868126";"";"0";"284.34";"0";"3.56";"1759";"COc1cccc2sc(NC(=O)c3ccccc3)nc12";"PPB";"";"98.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158841";"";"0";"509.45";"2";"5.38";"3056";"OC(=O)[C@H](Cc1ccc(F)cc1)N2CCC(CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4)CC2";"PPB";"";"78.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL559968";"";"0";"405.24";"0";"2.2";"2844";"Clc1ccccc1CCNC(=O)c2cc(ccc2Cl)N3N=CC(=O)NC3=O";"PPB";"";"97.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164565";"";"0";"377.37";"0";"3.47";"5427";"CCN(CCO)C(=O)c1cc2cccnn2c1c3cccc(c3)C(F)(F)F";"PPB";"";"91.28";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1256568";"";"0";"196.16";"0";"-0.4";"428";"OC(=O)CNC(=O)c1ncccc1O";"PPB";"";"75.97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2071493";"";"0";"299.35";"0";"3.46";"4809";"CC(C)C(NC(=O)c1ccccc1)C(=O)c2ccc(F)cc2";"PPB";"";"91.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164042";"";"0";"474.41";"0";"3.57";"5269";"Fc1cnc(CCN2C(C(=O)NCc3cccc(OC(F)(F)F)c3)c4ccccc4C2=O)nc1";"PPB";"";"82.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2029721";"";"0";"423.56";"0";"3.06";"4322";"CN(CC(=O)NC1CC1)C(=O)c2ccc3c(c2)c4CC(CCc4n3C)C5CCOCC5";"PPB";"";"97.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1461208";"";"0";"454.57";"0";"2.18";"2640";"COc1ccc(cc1)S(=O)(=O)N2CC(C)N(CC2C)S(=O)(=O)c3ccc(OC)cc3";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1818303";"";"0";"565.8";"2";"5.71";"4889";"CN(C)CCC1CCN(CC1)c2cc(C(=O)NC[C@@H]3CC[C@@H](CNC(=O)OCC(C)(C)C)CC3)c4ccccc4n2";"PPB";"";"98.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2325645";"";"0";"469.88";"0";"4.45";"5650";"Fc1cc(c(F)cc1Oc2ccc(Cl)cc2c3cn[nH]c3)S(=O)(=O)Nc4ncns4";"PPB";"";"99.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934414";"";"0";"446.62";"0";"4.58";"5460";"C[C@H](NC(=O)c1c(C)nn(C2CCCC2)c1NS(=O)(=O)c3ccc(C)cc3)C(C)(C)C";"PPB";"";"97.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178390";"";"0";"395.5";"0";"4.42";"4643";"CC(C)c1nc(C)c(nc1C(=O)N)c2ccc(cc2)[C@@H]3CC[C@@H](CC(=O)O)CC3";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1271162";"";"0";"459.59";"0";"2.88";"3578";"CN1CCC(CC1)N2CCN(CC2)C(=O)[C@H](NC(=O)c3ccc4cc[nH]c4c3)c5ccccc5";"PPB";"";"45.98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1945033";"";"0";"464.59";"0";"2.89";"3883";"O[C@@H](CNCCc1cccc(CNCCc2ccccn2)c1)c3ccc(O)c4NC(=O)Sc34";"PPB";"";"85.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1354035";"";"0";"266.38";"0";"1.31";"1773";"COCCNCC(=O)NC12CC3CC(CC(C3)C1)C2";"PPB";"";"51.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2021706";"";"0";"450.01";"0";"2.91";"5846";"CCC[C@@H](CNC(=O)c1nc(Cl)c(N)nc1N)[N+](C)(C)CCCc2ccc(OC)cc2";"PPB";"";"54.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158793";"";"0";"486.6";"0";"4.91";"3640";"Cc1cc(F)ccc1OC2CCN(CC3CCN(CC3)[C@@](C)(Cc4ccc(F)cc4)C(=O)O)CC2";"PPB";"";"55.16";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL605846";"OLODATEROL";"4";"386.45";"0";"2.38";"5606";"COc1ccc(CC(C)(C)NC[C@H](O)c2cc(O)cc3NC(=O)COc23)cc1";"PPB";"";"55.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1020";"TOLMETIN";"4";"257.29";"0";"2.19";"254";"Cc1ccc(cc1)C(=O)c2ccc(CC(=O)O)n2C";"PPB";"";"97.13";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2165180";"";"0";"380.45";"0";"1.76";"5140";"OCCN(Cc1cccc2ccccc12)C3=CC(=NC(=O)N3)N4CCOCC4";"PPB";"";"84.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL380648";"";"0";"380.42";"0";"2.09";"4190";"Fc1ccc(CC2=NNC(=O)c3ccccc23)cc1C(=O)N4CCCNCC4";"PPB";"";"40.34";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778638";"";"0";"422.81";"0";"4.28";"2741";"CCS(=O)(=O)c1ccc(c(Cl)c1)c2cc(ccc2OCC(=O)O)C(F)(F)F";"PPB";"";"96.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2216902";"";"0";"580.72";"2";"2.3";"5826";"CC(C)c1nc2ccccc2n1c3nc(N4CCOCC4)c5nc(OC6CN(C6)C7CCS(=O)(=O)CC7)n(C)c5n3";"PPB";"";"78.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL378730";"";"0";"364.83";"1";"5.21";"2464";"Cc1ccc2c(c1)c(c(C)n2CC(=O)O)c3ccnc4c(Cl)cccc34";"PPB";"";"99.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1818293";"";"0";"534.71";"1";"4.72";"4788";"CN(C)CCn1cc(cn1)c2cc(C(=O)NC[C@@H]3CC[C@@H](CNC(=O)OC(C)(C)C)CC3)c4ccccc4n2";"PPB";"";"93.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL320876";"";"0";"588.56";"2";"1.34";"5710";"COc1cc(cc(OC)c1O)[C@H]2[C@@H]3C(COC3=O)C(O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)c6cc7OCOc7cc26";"PPB";"";"78.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL207881";"GW9508";"0";"347.41";"1";"5.11";"4072";"OC(=O)CCc1ccc(NCc2cccc(Oc3ccccc3)c2)cc1";"PPB";"";"99.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934417";"";"0";"464.63";"0";"4.06";"5519";"COCCC(C)n1nc(C)c(C(=O)N[C@@H](C)C(C)(C)C)c1NS(=O)(=O)c2ccc(C)cc2";"PPB";"";"72.45";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178933";"";"0";"353.47";"0";"3.52";"4702";"Cc1nc(C)c(nc1C(=O)N)c2ccc(cc2)[C@@H]3CC[C@@H](CCO)CC3";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1615283";"";"0";"502.66";"2";"5.42";"4250";"CC(C)(C)OC(=O)NC[C@@H]1CC[C@@H](CNC(=O)c2cc(nc3ccccc23)c4ccc(CN)cc4)CC1";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL111402";"";"0";"482.67";"1";"5.38";"1851";"Oc1ccc(CCNCCCSCCOCCc2cccc3ccccc23)c4sc(O)nc14";"PPB";"";"98.78";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL563498";"";"0";"212.21";"0";"1.3";"3043";"Nc1nc(O)c(C#N)c(n1)c2ccccc2";"PPB";"";"96.34";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL236788";"";"0";"489.6";"0";"2.93";"5306";"CCOc1cc(CN2CCC(CC2)Nc3oc4ccc(cc4n3)S(=O)(=O)N)cc(OCC)c1N";"PPB";"";"89.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1254771";"SAFOTIBANT";"2";"502.64";"1";"1.96";"5724";"COc1cc(C)c(c(C)c1)S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(cc2)C3=NCCN3";"PPB";"";"74.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164567";"";"0";"377.37";"0";"3.5";"5499";"CCN(CCO)C(=O)c1cc2cccnc2n1c3cccc(c3)C(F)(F)F";"PPB";"";"75.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2325635";"";"0";"547.45";"1";"4.92";"5639";"Clc1ccc(Oc2ccc(cc2C#N)S(=O)(=O)Nc3ncc(Cl)s3)c(c1)c4ccnn4C5CNC5";"PPB";"";"98.58";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL22183";"";"0";"272.42";"0";"3.79";"4862";"CN(C)Cc1ccccc1Sc2ccc(C)cc2N";"PPB";"";"90.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1518";"PROPYLTHIOURACIL";"4";"170.24";"0";"1.38";"55";"CCCC1=CC(=O)NC(=S)N1";"PPB";"";"37.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL105462";"";"0";"873.03";"2";"1.03";"4464";"C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc3c[nH]cn3)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)N[C@H](Cc6ccccc6)C(=O)N[C@@H](CCCCN)C(=O)N";"PPB";"";"73.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL73048";"";"0";"345.73";"0";"2";"2559";"C[C@@](O)(C(=O)Nc1ccc(cc1Cl)S(=O)(=O)C)C(F)(F)F";"PPB";"";"84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1683035";"";"0";"428.44";"0";"2.51";"4423";"COc1cc2nnc(C(=O)N)c(Nc3ccc(F)cc3F)c2cc1N4CCN(C)CC4";"PPB";"";"84.3";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL140684";"";"0";"402.39";"0";"2.76";"2252";"CN(c1ccccc1)S(=O)(=O)c2ccc(NC(=O)C(C)(O)C(F)(F)F)cc2";"PPB";"";"97.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1689127";"";"0";"434.9";"0";"3.22";"3502";"C[C@H]1CN(Cc2cc(Cl)ccc2OCC(=O)O)CCN1C(=O)Cc3ccc(F)cc3";"PPB";"";"90.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL480558";"";"0";"311.86";"0";"2.48";"5570";"CCC(CC)[C@@H](CO)NS(=O)(=O)c1ccc(Cl)s1";"PPB";"";"90.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1683036";"";"0";"424.48";"0";"2.68";"4432";"COc1cc2nnc(C(=O)N)c(Nc3ccc(C)cc3F)c2cc1N4CCN(C)CC4";"PPB";"";"93.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL71";"CHLORPROMAZINE";"4";"318.87";"0";"4.89";"11";"CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13";"PPB";"";"98.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL601882";"";"0";"326.78";"0";"4.58";"5405";"CN(C(=O)c1c(C)onc1c2ccccc2)c3ccc(Cl)cc3";"PPB";"";"92.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2069411";"";"0";"459.42";"0";"3.31";"4678";"OCc1ccc(cn1)c2cccc3OC[C@H](Cc23)NC(=O)c4ccc(OCC(F)(F)F)nc4";"PPB";"";"92.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL70";"MORPHINE";"4";"285.34";"0";"1.2";"1859";"CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35";"PPB";"";"17.28";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1322893";"";"0";"297.34";"0";"2.46";"3803";"COc1ccccc1c2csc(n2)n3ncc(C#N)c3N";"PPB";"";"47.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1422";"SITAGLIPTIN";"4";"407.32";"0";"2.02";"3325";"N[C@@H](CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc3cc(F)c(F)cc3F";"PPB";"";"21.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL423";"BETAXOLOL";"4";"307.43";"0";"2.39";"1767";"CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1";"PPB";"";"59.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL742";"KETAMINE";"4";"237.73";"0";"2.9";"455";"CNC1(CCCCC1=O)c2ccccc2Cl";"PPB";"";"44.84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2071601";"";"0";"428.79";"0";"4.9";"5266";"CC(C)C(NC(=O)c1cc(Cl)ccc1C(F)(F)F)C(=O)c2ccc(cc2)[N+](=O)[O-]";"PPB";"";"97.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2064327";"";"0";"354.38";"0";"3.6";"4204";"Cc1cc(F)ccc1Oc2cccc3C(=O)C=C(Nc23)N4CCOCC4";"PPB";"";"91.46";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL564737";"";"0";"401.89";"0";"4.52";"3447";"OC(=O)c1ccccc1c2ccc(Cl)c(c2)C(=O)NCC3(O)CCCCCC3";"PPB";"";"90.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL322479";"";"0";"442.63";"1";"5.44";"1875";"CC(C)(CCCCCOCCc1ccccc1)NCCc2ccc(O)c3nc(O)sc23";"PPB";"";"97.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL360227";"";"0";"469.89";"0";"3.38";"5641";"CCN(CC)CCN1C(=O)[C@@](O)(c2ccccc2Cl)c3c1cc(cc3C(F)(F)F)C(=O)N";"PPB";"";"78.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL62136";"T091317";"0";"481.34";"0";"4.76";"1763";"OC(c1ccc(cc1)N(CC(F)(F)F)S(=O)(=O)c2ccccc2)(C(F)(F)F)C(F)(F)F";"PPB";"";"99.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1416617";"";"0";"249.32";"0";"3.43";"1180";"Cc1nn(c(N)c1c2ccccc2)c3ccccc3";"PPB";"";"95.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL551813";"ACTIMIS";"0";"501.51";"1";"4.1";"5243";"CN(C)c1nc(Cc2ccc(NC(=O)c3ccc(cc3)C(F)(F)F)cc2)nc(N(C)C)c1CC(=O)O";"PPB";"";"99.75";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1689128";"";"0";"451.35";"0";"3.73";"3488";"C[C@H]1CN(Cc2cc(Cl)ccc2OCC(=O)O)CCN1C(=O)Cc3ccc(Cl)cc3";"PPB";"";"96.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL472";"GLYBURIDE";"4";"494.01";"0";"3.64";"454";"COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3";"PPB";"";"99.88";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL384903";"";"0";"362.23";"0";"4.06";"1784";"Oc1ccc(cc1N2C(=O)Nc3cc(ccc23)C(F)(F)F)C(F)(F)F";"PPB";"";"99.89";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1213085";"";"0";"507.53";"1";"4.28";"5652";"Cc1ccccc1N2C(=Nc3cccc(C)c3C2=O)Cn4nc(c5ccc(O)c(F)c5)c6c(N)ncnc46";"PPB";"";"96.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1017";"TELMISARTAN";"4";"514.63";"2";"7.26";"3544";"CCCc1nc2c(C)cc(cc2n1Cc3ccc(cc3)c4ccccc4C(=O)O)c5nc6ccccc6n5C";"PPB";"";"99.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147306";"";"0";"464.42";"0";"3.91";"5231";"COc1ncc(cn1)c2c(C)ccc(F)c2CCNC(=O)c3ccc(OCC(F)(F)F)nc3";"PPB";"";"95.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1201391";"TENIVASTATIN";"0";"436.59";"0";"4.11";"149";"CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@@H]12";"PPB";"";"97.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL323776";"";"0";"443.57";"0";"2.95";"1878";"CN(CCNCCc1ccc(O)c2nc(O)sc12)C(=O)CCOCCc3ccccc3";"PPB";"";"79.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164564";"";"0";"351.41";"0";"2.61";"5569";"COc1ccc(cc1)c2c(cc3cccnn23)C(=O)N4CCC[C@H]4CO";"PPB";"";"73.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL51";"KETANSERIN";"4";"395.43";"0";"2.42";"804";"Fc1ccc(cc1)C(=O)C2CCN(CCN3C(=O)Nc4ccccc4C3=O)CC2";"PPB";"";"99.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL509973";"";"0";"264.33";"0";"3.66";"3265";"CC(NC(=O)c1cc2ccccc2[nH]1)c3ccccc3";"PPB";"";"96.34";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2316404";"";"0";"390.44";"0";"3.42";"4199";"COc1ccc(NC(=O)c2ccnc3ccccc23)c(n1)C(=O)NCC4CCC4";"PPB";"";"99.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2086675";"";"0";"371.44";"0";"2.51";"4746";"CC(C)(C)OC(=O)N1CCN(CC1)c2ncc(OCc3ccncc3)cn2";"PPB";"";"96.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2177757";"";"0";"524.7";"1";"4.27";"5786";"O=C(Cc1ccccc1)Nc2nnc(CCSCCc3nnc(NC(=O)Cc4ccccc4)s3)s2";"PPB";"";"99.58";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778644";"";"0";"372.8";"0";"3.4";"2685";"CCS(=O)(=O)c1ccc(c(F)c1)c2cc(Cl)ccc2OCC(=O)O";"PPB";"";"94.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL578201";"";"0";"352.38";"0";"3.14";"4385";"C[C@H](Nc1nc(Nc2cc(C)[nH]n2)c(C)nc1C#N)c3ccc(F)cn3";"PPB";"";"81.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL214957";"";"0";"482.01";"1";"5.25";"3128";"COc1cc(ccc1OCCN2CCCC2)N3C=Nc4cc(sc4C3=O)c5ccc(Cl)cc5";"PPB";"";"99.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2325636";"";"0";"545.93";"2";"5.59";"5673";"Nc1cc(ccn1)c2cc(ccc2Oc3cc(F)c(cc3Cl)S(=O)(=O)Nc4ncns4)C(F)(F)F";"PPB";"";"99.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL65693";"";"0";"393.47";"0";"4.32";"5268";"CS(=O)(=O)Nc1ccc2[nH]c(Cc3ccc(Oc4ccccc4)cc3)nc2c1";"PPB";"";"99.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1917433";"";"0";"424.93";"0";"4.21";"2477";"Cc1c(Sc2ccc(Cl)cc2)c3c(NS(=O)(=O)C)cccc3n1CC(=O)O";"PPB";"";"99.69";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164045";"";"0";"490.41";"0";"3.28";"5309";"Oc1cccc2C(N(CCc3ncc(F)cn3)C(=O)c12)C(=O)NCc4ccc(OC(F)(F)F)cc4";"PPB";"";"95.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1818294";"";"0";"552.76";"1";"3.98";"4470";"CN(C)CCN1CCN(CC1)c2cc(C(=O)NC[C@@H]3CC[C@@H](CNC(=O)OC(C)(C)C)CC3)c4ccccc4n2";"PPB";"";"94.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1631095";"";"0";"442.32";"0";"3.77";"5655";"NC(=O)c1cc(C(=O)N)n(n1)c2cccc(c2)c3cc(ccc3C(F)(F)F)C(F)(F)F";"PPB";"";"94.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011441";"";"0";"384.66";"0";"2.76";"2265";"COc1nc(Br)cnc1NS(=O)(=O)c2ccc(Cl)s2";"PPB";"";"99.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL481611";"ODANACATIB";"3";"525.57";"1";"4.63";"4812";"CC(C)(F)C[C@H](N[C@@H](c1ccc(cc1)c2ccc(cc2)S(=O)(=O)C)C(F)(F)F)C(=O)NC3(CC3)C#N";"PPB";"";"96.34";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916271";"";"0";"519.63";"2";"5.12";"5041";"CCN(C1CCCCC1)C(=O)c2cnn(c2NS(=O)(=O)c3ccc(cc3)c4ocnc4)c5ccccc5";"PPB";"";"99.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL259850";"";"0";"308.32";"0";"2.38";"1852";"COc1ccc(CNC(=O)Nc2ncc(s2)[N+](=O)[O-])cc1";"PPB";"";"98.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2338406";"";"0";"429.39";"0";"3.53";"5573";"CC(C)(C)NC(=O)NCCN1CCC(CNC(=O)c2cc(Cl)cc(Cl)c2)CC1";"PPB";"";"83.04";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1957841";"";"0";"360.42";"0";"2.53";"5197";"O=C1C=C(N=C2N(Cc3cccc4ccccc34)C=CN12)N5CCOCC5";"PPB";"";"95.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL152640";"";"0";"450.54";"1";"5.26";"4398";"Cc1cc(C)c(C)c(Cn2ccc3c(\C=N\NC(=O)c4ccc(O)c(c4)C#N)cccc23)c1C";"PPB";"";"99.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1467761";"";"0";"394.54";"0";"4.26";"376";"Cc1csc2c(ncnc12)N3CCN(CC3)C(=O)c4ccc(cc4)C(C)(C)C";"PPB";"";"99.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147221";"";"0";"460.46";"0";"4.16";"5018";"COc1ncc(cn1)c2cccc(C)c2CCNC(=O)c3ccc(OCCC(F)(F)F)nc3";"PPB";"";"94.44";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL219046";"";"0";"367.83";"0";"4.76";"4619";"OC(=O)c1c(O)c(Cc2ccc(Cl)cc2)nc3c4CCCCc4ccc13";"PPB";"";"99.86";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2181927";"FINERENONE";"3";"378.43";"0";"2.99";"5874";"CCOc1ncc(C)c2NC(=C([C@@H](c3ccc(cc3OC)C#N)c12)C(=O)N)C";"PPB";"";"99.93";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916284";"";"0";"508.57";"2";"5.16";"5121";"C[C@H](NC(=O)c1c(NS(=O)(=O)c2ccc(C)cc2)n(nc1C(F)(F)F)c3ccccc3)C(C)(C)C";"PPB";"";"99.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2074773";"";"0";"262.74";"0";"1.44";"3146";"OCCNC(=S)NCc1cccc(Cl)c1F";"PPB";"";"84";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2316385";"";"0";"436.54";"0";"3.29";"4393";"C[S+]([O-])Cc1ccc(C(=O)Nc2nccnc2C(=O)NCC3CCC3)c4ccccc14";"PPB";"";"90.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2151326";"";"0";"387.35";"0";"2.16";"4331";"COc1cc(Nc2nc3c(cc2F)ncn3[C@@H](CO)c4ccc(F)cn4)n[nH]1";"PPB";"";"63.47";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2325638";"";"0";"487.87";"0";"4.59";"5645";"Fc1cc(Oc2cc(F)c(cc2F)S(=O)(=O)Nc3ncns3)c(cc1Cl)c4cn[nH]c4";"PPB";"";"99.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL96076";"";"0";"322.41";"0";"3.74";"1098";"COc1ccc(CN2CCc3c(C2)[nH]c4ccccc34)cc1OC";"PPB";"";"95.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1924032";"";"0";"381.49";"0";"3.41";"4263";"CC(N1CCC(F)(F)CC1)(C(=O)OC2CC[N+](C)(C)CC2)c3ccccc3";"PPB";"";"37.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934268";"";"0";"406.55";"0";"3.49";"5485";"CCn1nc(C)c(C(=O)N[C@@H](C)C(C)(C)C)c1NS(=O)(=O)c2ccc(C)cc2";"PPB";"";"95.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2048863";"";"0";"323.81";"0";"2.2";"4763";"N[C@H]1CCN(C1)c2c(Cl)cccc2\C=C\3/SC(=O)NC3=O";"PPB";"";"95.33";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL247828";"";"0";"549.59";"1";"4.89";"4770";"CC(C)N1C(=O)[C@@H](CCc2ccccc12)NC(=O)[C@@H](Cc3ccccc3OC(F)(F)F)NC(=O)OC(C)(C)C";"PPB";"";"99.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178951";"";"0";"353.42";"0";"3.3";"4442";"Cc1ncc(nc1c2ccc(cc2)[C@@H]3CC[C@@H](CC(=O)O)CC3)C(=O)N";"PPB";"";"96.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164373";"";"0";"468.42";"0";"4.98";"4669";"FC(F)(F)Oc1ccc(CNC(=O)C2N(C3CCC(F)(F)CC3)C(=O)c4ccccc24)cc1";"PPB";"";"96.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL212521";"";"0";"307.4";"0";"2.64";"3931";"CC[C@H](N)C(=O)N[C@@H](Cc1ccc(cc1)c2ccccc2)C#N";"PPB";"";"92.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916289";"";"0";"526.56";"2";"5.3";"5189";"C[C@H](NC(=O)c1c(C)nn(c1NS(=O)(=O)c2ccc(cc2)C(F)(F)F)c3ccc(F)cc3)C(C)(C)C";"PPB";"";"97.07";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL8809";"RACLOPRIDE";"1";"347.24";"0";"2.92";"1842";"CCN1CCC[C@H]1CNC(=O)c2c(O)c(Cl)cc(Cl)c2OC";"PPB";"";"44.27";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL109980";"";"0";"610.58";"1";"2.32";"5444";"CC(C)(N)C(=O)N[C@H](COCc1ccc(F)cc1F)C(=O)N2CCC3=NN(CC(F)(F)F)C(=O)[C@]3(Cc4ccccn4)C2";"PPB";"";"48.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1807821";"";"0";"432.54";"0";"2.58";"3519";"O[C@@H](CNCCCOCCOCCc1ccccc1)c2ccc(O)c3NC(=O)Sc23";"PPB";"";"53.45";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2313227";"";"0";"352.37";"0";"3.46";"5172";"COCCN(c1cccnc1)P(=O)(c2ccccc2)c3ccccc3";"PPB";"";"62.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147222";"";"0";"464.42";"0";"3.99";"4942";"COc1ncc(cn1)c2cccc(F)c2CCNC(=O)c3ccc(OCCC(F)(F)F)nc3";"PPB";"";"93.24";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL301856";"";"0";"221.65";"0";"2.08";"5313";"Nc1nc(O)c(Cl)c(n1)c2ccccc2";"PPB";"";"93.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2312921";"";"0";"413.48";"0";"4.24";"5195";"CCCN(c1cccc(c1)S(=O)(=O)C)P(=O)(c2ccccc2)c3ccccc3";"PPB";"";"81.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL522460";"";"0";"404.56";"0";"3.94";"5236";"Cc1ccccc1CN2CCC(CC2)N3CCC(CC3)N4C(=O)Nc5ccccc45";"PPB";"";"70.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL482552";"";"0";"463.55";"0";"3.83";"5408";"O=C(Nc1ccc(CN2CCNCC2)cc1c3nc4ccccc4[nH]3)c5cnc6ccccc6n5";"PPB";"";"91.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1473";"FLUTICASONE PROPIONATE";"4";"500.58";"1";"4.43";"1748";"CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF";"PPB";"";"98.47";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL457";"GEMFIBROZIL";"4";"250.34";"0";"3.57";"168";"Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1";"PPB";"";"98.47";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2018969";"";"0";"549.07";"1";"4";"5667";"COc1cccc2c1c(NS(=O)(=O)c3ccc(Cl)s3)nn2Cc4cccc(CNC(=O)C(C)(C)O)c4";"PPB";"";"99.18";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1621884";"";"0";"318.34";"0";"3.2";"1342";"COCCCCC(=NOCCN)c1ccc(cc1)C(F)(F)F";"PPB";"";"77.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL490";"PAROXETINE";"4";"329.37";"0";"3.33";"2753";"Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc3ccc4OCOc4c3";"PPB";"";"94.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147316";"";"0";"482.41";"0";"4.15";"5583";"COc1cnc(cn1)c2ccccc2C(F)(F)CNC(=O)c3ccc(COCC(F)(F)F)nc3";"PPB";"";"94.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1818187";"";"0";"473.62";"1";"5.96";"3904";"CC(C)(C)OC(=O)NC[C@@H]1CC[C@@H](CNC(=O)c2cc(nc3ccccc23)c4ccccc4)CC1";"PPB";"";"99.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1492153";"";"0";"342.68";"0";"4.14";"2915";"Fc1ccc(cc1)c2cc(nc(n2)n3cc(Cl)cn3)C(F)(F)F";"PPB";"";"99.52";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1387923";"";"0";"331.79";"0";"3.9";"1266";"Clc1cccc(NC(=O)Nc2nnc(s2)c3ccncc3)c1";"PPB";"";"99.54";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2204343";"";"0";"391.95";"";"";"4294";"O[Si]1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL397647";"";"0";"408.35";"1";"5";"5301";"C[N+](C)(Cc1ccc(NC(=O)c2ccc(Cl)c(Cl)c2)cc1)C3CCOCC3";"PPB";"";"61.31";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL520733";"SEMAGACESTAT";"3";"361.44";"0";"0.38";"5089";"CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@@H]1C(=O)N(C)CCc2ccccc12";"PPB";"";"20.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2207665";"";"0";"522.35";"1";"3.35";"2689";"CN1C=C(C(=O)NC[C@@H](O)CN2CCC(CC2)Oc3ccc(Cl)c(Cl)c3)C(=CC1=O)C(F)(F)F";"PPB";"";"89.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934418";"";"0";"478.68";"0";"4.53";"5495";"C[C@H](NC(=O)c1c(C)nn(C2CCSCC2)c1NS(=O)(=O)c3ccc(C)cc3)C(C)(C)C";"PPB";"";"93.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL564607";"";"0";"423.94";"1";"5.65";"3172";"OC(=O)c1ccc(cc1)c2ccc(Cl)c(c2)C(=O)NCC34CC5CC(CC(C5)C3)C4";"PPB";"";"99.26";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL139";"DICLOFENAC";"4";"296.15";"0";"4.36";"667";"OC(=O)Cc1ccccc1Nc2c(Cl)cccc2Cl";"PPB";"";"99.28";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2151322";"";"0";"397.41";"0";"2.61";"4321";"CC(C)Oc1cc(n[nH]1)n2cnc3ccc(N[C@@H](CO)c4ccc(F)cn4)nc23";"PPB";"";"81.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL148674";"VARESPLADIB";"2";"380.4";"0";"2.38";"1785";"CCc1c(C(=O)C(=O)N)c2c(OCC(=O)O)cccc2n1Cc3ccccc3";"PPB";"";"92.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916086";"";"0";"446.53";"0";"3.91";"3669";"Cc1ccc(cc1)S(=O)(=O)Nc2c(cnn2c3ccccc3)C(=O)NCc4ccccc4";"PPB";"";"99.34";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164372";"";"0";"434.41";"0";"3.58";"4396";"FC(F)(F)Oc1ccc(CNC(=O)C2N(C[C@@H]3CCCO3)C(=O)c4ccccc24)cc1";"PPB";"";"93.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL550436";"";"0";"438.83";"0";"4.41";"4742";"C[C@H](CO)N1C=Cc2c(NC(=O)Cc3ccc(Cl)c(c3)C(F)(F)F)cccc2C1=O";"PPB";"";"96.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2062774";"";"0";"382.46";"0";"4.01";"4824";"CCOc1noc2cc(OCCC3CCN(CC3)c4ccc(C)nn4)ccc12";"PPB";"";"99.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2216839";"";"0";"428.5";"0";"4.37";"5717";"C[C@@H]1CN(Cc2oc(nn2)c3cc(cc4[nH]ncc34)c5cccc6[nH]ccc56)C[C@H](C)O1";"PPB";"";"96.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178388";"";"0";"403.43";"0";"4.24";"4677";"Cc1nc(C(F)F)c(nc1c2ccc(cc2)[C@@H]3CC[C@@H](CC(=O)O)CC3)C(=O)N";"PPB";"";"96.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916280";"";"0";"426.54";"0";"3.82";"5134";"CCC(C)NC(=O)c1c(C)nn(c1NS(=O)(=O)c2ccc(C)cc2)c3ccccc3";"PPB";"";"96.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL229430";"AMG-517";"1";"430.41";"1";"5.52";"4444";"CC(=O)Nc1nc2c(Oc3cc(ncn3)c4ccc(cc4)C(F)(F)F)cccc2s1";"PPB";"";"99.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL520714";"";"0";"463.89";"0";"4.53";"3191";"FC(F)(F)c1ccc(cc1)n2ccc(CN3CC(C3)NC(=O)COc4cccc(Cl)c4)c2";"PPB";"";"99.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1090488";"PF-00446687";"2";"470.6";"0";"4.78";"5421";"C[C@@H]1CN(C[C@H](C)[C@@]1(O)c2ccccc2)C(=O)[C@@H]3CN(C[C@H]3c4ccc(F)cc4F)C(C)(C)C";"PPB";"";"81.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179273";"";"0";"512.01";"2";"5.17";"5481";"CCC[C@@H](N1CCC[C@@H](C1)N2C=C(C)C(=O)NC2=O)c3ccc(C(=O)O)c(Oc4cccc(Cl)c4)c3";"PPB";"";"98.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL461384";"";"0";"505.53";"2";"3.56";"4416";"CC(C)c1noc(n1)C2CCN(CC2)c3ncnc(Nc4ccc(cc4F)S(=O)(=O)C)c3[N+](=O)[O-]";"PPB";"";"98.4";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2326624";"";"0";"576.1";"1";"3.21";"5669";"COc1cccc2c1c(NS(=O)(=O)c3ccc(Cl)s3)nn2Cc4cccc(CNC(=O)[C@@H]5COCCN5)c4";"PPB";"";"98.44";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1210207";"";"0";"491.61";"1";"5.39";"5636";"CCOc1cc(CN2CCC(CC2)NC(=O)c3cncc(C)c3)cc(OCC)c1c4ccc(F)cc4";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147474";"";"0";"468.96";"0";"4.93";"5586";"COc1cc(ccc1OC[C@H](O)C2CC2)N3C=Nc4cc(sc4C3=O)c5ccc(Cl)cc5";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1369407";"";"0";"473.41";"1";"7.49";"1336";"CC(C)N=C1C=C2N(c3ccc(Cl)cc3)c4ccccc4N=C2C=C1Nc5ccc(Cl)cc5";"PPB";"";"99.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1287920";"";"0";"352.46";"0";"3.23";"3350";"NC(=O)c1cnc(N[C@H]2CCCNC2)c3cc(sc13)c4ccccc4";"PPB";"";"77.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1924047";"";"0";"447.64";"0";"4.78";"4605";"C[C@@](N1CCCCC1)(C(=O)O[C@H]2C[N+]3(CCc4ccccc4)CCC2CC3)c5ccccc5";"PPB";"";"78.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1778628";"";"0";"321.25";"0";"3.71";"2888";"OC(=O)COc1ccc(cc1c2cccc(c2)C#N)C(F)(F)F";"PPB";"";"96.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178939";"";"0";"444.56";"0";"2.6";"4686";"Cc1nc(C)c(nc1C(=O)N)c2ccc(cc2)[C@@H]3CC[C@@H](CC(=O)NS(=O)(=O)C)CC3";"PPB";"";"96.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL223166";"";"0";"299.37";"0";"2.8";"5371";"COc1ccccc1O[C@H]([C@@H]2CNCCO2)c3ccccc3";"PPB";"";"23.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL645";"BISOPROLOL";"4";"325.45";"0";"2.37";"1723";"CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1";"PPB";"";"23.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164740";"";"0";"461.52";"0";"1.26";"4212";"O[C@@H]1CN(CCN2C(=O)C=Cc3ccc(cc23)C#N)CC[C@@H]1NCc4cc5OCCOc5cn4";"PPB";"";"26.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2151324";"";"0";"415.4";"0";"2.94";"4318";"CC(C)Oc1cc(Nc2nc3c(cc2F)ncn3[C@@H](CO)c4ccc(F)cn4)n[nH]1";"PPB";"";"88.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1689111";"";"0";"438.93";"0";"2.45";"3355";"OC(=O)COc1ccc(Cl)cc1CN2CCN(CC2)S(=O)(=O)Cc3ccccc3";"PPB";"";"88.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164395";"";"0";"470.45";"0";"3.47";"4520";"FC(F)(F)COc1ccc(CNC(=O)C2N(CCc3ccccn3)C(=O)c4ccccc24)cn1";"PPB";"";"62.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL170614";"";"0";"164.23";"0";"2.06";"1810";"C(c1ccsc1)c2c[nH]cn2";"PPB";"";"62.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179270";"";"0";"483.95";"0";"4.39";"5380";"C[C@H](N1CCC[C@@H](C1)N2C=C(C)C(=O)NC2=O)c3ccc(C(=O)O)c(Oc4cccc(Cl)c4)c3";"PPB";"";"97.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2177173";"";"0";"536.66";"1";"1.91";"1930";"CN1CCN(CC1)S(=O)(=O)c2ccc(cc2)c3cnc(N)c(n3)C(=O)Nc4cnccc4CN5CCCC5";"PPB";"";"90.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1643194";"";"0";"485.37";"1";"5.46";"5295";"Cc1cc(CN2Cc3ccccc3C2C(=O)Nc4ccc(Cl)cc4Cl)ccc1OCC(=O)O";"PPB";"";"99.86";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934415";"";"0";"460.64";"0";"4.97";"5433";"C[C@H](NC(=O)c1c(C)nn(C2CCCCC2)c1NS(=O)(=O)c3ccc(C)cc3)C(C)(C)C";"PPB";"";"96.34";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158436";"";"0";"336.4";"0";"2.37";"4963";"O=C1NC(=NC(=C1)N2CCOCC2)NCc3cccc4ccccc34";"PPB";"";"97.49";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2113096";"";"0";"359.42";"0";"3.71";"4601";"Cc1nccn1c2sc(Nc3cnccn3)nc2c4cccc(c4)C#N";"PPB";"";"95.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916260";"";"0";"404.54";"0";"3.48";"5000";"CCC(CC)NC(=O)c1cnn(c1NS(=O)(=O)C2CCCC2)c3ccccc3";"PPB";"";"99.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916281";"";"0";"454.6";"0";"4.45";"5057";"CC(NC(=O)c1c(C)nn(c1NS(=O)(=O)c2ccc(C)cc2)c3ccccc3)C(C)(C)C";"PPB";"";"95.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2021721";"";"0";"756.97";"2";"6.34";"5178";"COc1ccc2cc(ccc2c1)S(=O)(=O)N[C@H](CC(=O)N[C@H](Cc3ccc(CN4[C@H](C)CCC[C@@H]4C)cc3)C(=O)N(C)C(C)C)c5ccc6OCOc6c5";"PPB";"";"95.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335893";"";"0";"427.51";"0";"4.65";"4486";"COCCC(=O)N[C@H](C)c1ccc(Nc2ncc3cc(ccc3n2)c4ccncc4)cc1";"PPB";"";"95.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178573";"";"0";"495.87";"0";"4.37";"5637";"Cc1cnc(C(=O)c2ncnc3[nH]ccc23)c(NS(=O)(=O)c4ccc(Cl)c(c4)C(F)(F)F)c1";"PPB";"";"99.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL278262";"";"0";"341.37";"1";"5.32";"5012";"[O-][N+](=O)c1ccc(cc1)c2nc(c3ccccc3)c([nH]2)c4ccccc4";"PPB";"";"99.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2349318";"";"0";"415.54";"0";"3.68";"2408";"CCC[C@H](CO)Nc1nc(S[C@@H](C)c2cccc(c2)C#N)nc3NC(=O)Sc13";"PPB";"";"99.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2216859";"NEMIRALISIB";"0";"440.55";"0";"4.89";"5882";"CC(C)N1CCN(Cc2oc(nc2)c3cc(cc4[nH]ncc34)c5cccc6[nH]ccc56)CC1";"PPB";"";"96.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1779503";"";"0";"370.8";"0";"1.55";"2871";"Clc1ccc(cc1C(=O)NCCc2ccccc2)N3N=CC(=O)NC3=O";"PPB";"";"96.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1818194";"";"0";"474.61";"1";"5.36";"4085";"CC(C)(C)OC(=O)NC[C@@H]1CC[C@@H](CNC(=O)c2cc(nc3ccccc23)c4ccncc4)CC1";"PPB";"";"98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL327715";"";"0";"328.38";"0";"3.89";"4178";"NC(=N)c1ccc2[nH]c(nc2c1)c3cccc(c3O)c4ccccc4";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL98406";"";"0";"168.2";"0";"2.02";"1669";"Nc1nc2ccc(F)cc2s1";"PPB";"";"75.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158835";"";"0";"491.46";"1";"5.24";"2410";"OC(=O)[C@H](Cc1ccccc1)N2CCC(CN3CCC(CC3)Oc4ccc(Cl)c(Cl)c4)CC2";"PPB";"";"81.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL304087";"MERIMEPODIB";"2";"452.47";"0";"4.01";"4929";"COc1cc(NC(=O)Nc2cccc(CNC(=O)O[C@H]3CCOC3)c2)ccc1c4ocnc4";"PPB";"";"99.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL551170";"";"0";"414.89";"0";"2.52";"2838";"Clc1ccc(cc1C(=O)NCC23CC4CC(CC(C4)C2)C3)N5N=CC(=O)NC5=O";"PPB";"";"98.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL457608";"";"0";"373.82";"0";"4.18";"3559";"C[C@H](Nc1ncc(Cl)c(Nc2cc([nH]n2)C3CC3)n1)c4ccc(F)cn4";"PPB";"";"99.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1092240";"";"0";"475.54";"1";"3.87";"3399";"[O-][N+](=O)c1c(Nc2ccc(cc2)n3cncn3)ncnc1N4CCC(CC4)Sc5ccccn5";"PPB";"";"99.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1818297";"";"0";"523.72";"1";"4.86";"4531";"CC(C)(C)OC(=O)NC[C@@H]1CC[C@@H](CNC(=O)c2cc(nc3ccccc23)N4CCC(CCN)CC4)CC1";"PPB";"";"96.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2312918";"";"0";"326.34";"0";"3.82";"5091";"CCCN(c1ccon1)P(=O)(c2ccccc2)c3ccccc3";"PPB";"";"84.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2312933";"";"0";"336.38";"0";"4.23";"4881";"CCCN(c1cccnc1)P(=O)(c2ccccc2)c3ccccc3";"PPB";"";"84.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1963462";"";"0";"330.49";"0";"3.92";"3737";"C[C@@](C1CCCC1)(C(=O)OC2CC[N+](C)(C)CC2)c3ccccc3";"PPB";"";"61.31";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2152523";"";"0";"348.53";"1";"5.44";"4820";"C1CCN(CC1)[C@@H]([C@H](N2CCCCC2)c3ccccc3)c4ccccc4";"PPB";"";"63.47";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1080786";"";"0";"311.41";"0";"2.18";"5082";"N[C@@H](Cc1cccs1)C(=O)N[C@]2(C[C@H]2c3ccccc3)C#N";"PPB";"";"70.58";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916279";"";"0";"440.57";"0";"4.07";"5133";"Cc1ccc(cc1)S(=O)(=O)Nc2c(C(=O)NCC(C)(C)C)c(C)nn2c3ccccc3";"PPB";"";"96.65";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158438";"";"0";"320.78";"0";"1.87";"4993";"Clc1cccc(CNC2=NC(=CC(=O)N2)N3CCOCC3)c1";"PPB";"";"95.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL205412";"";"0";"589.64";"1";"4.59";"4358";"CN(Cc1ccc(cc1)c2ccccc2S(=O)(=O)N)C(=O)[C@@H]3CCC[C@H]3C(=O)NCc4ccc(OC(F)(F)F)cc4";"PPB";"";"99.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2178384";"";"0";"369.49";"0";"3.83";"4524";"Cc1ncc(nc1c2ccc(cc2)[C@@H]3CC[C@@H](CC(=O)O)CC3)C(=S)N";"PPB";"";"99.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL584926";"";"0";"422.44";"0";"3.37";"4466";"COc1ccc(cc1C)C2(N=C(N)N(C)C2=O)c3ccc(F)c(c3)c4cccnc4F";"PPB";"";"99.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1890471";"";"0";"360.17";"0";"2.32";"3395";"NC(=O)c1ccc(cc1)n2nnnc2Oc3ccc(Br)cc3";"PPB";"";"91.28";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL402831";"";"0";"490.82";"0";"4.53";"5159";"C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(cc1F)c2cc(Cl)cc(F)c2c3noc(C)n3";"PPB";"";"96.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL482436";"";"0";"543.05";"1";"2.65";"4757";"CCCN1C(=O)Nc2nc([nH]c2C1=O)c3ccc(cc3)S(=O)(=O)N4CCN(Cc5ccc(Cl)cc5)CC4";"PPB";"";"99.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1934267";"";"0";"420.58";"0";"4.05";"5109";"CC(C)n1nc(C)c(C(=O)N[C@@H](C)C(C)(C)C)c1NS(=O)(=O)c2ccc(C)cc2";"PPB";"";"95.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011127";"";"0";"473.58";"0";"2.69";"4707";"CC(C)N1Cc2c(nc(nc2C1=O)N3CCN(CC3)C(=O)C)N(C)Cc4cc5ccccc5cn4";"PPB";"";"66.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL907";"CARBOXYLIC ACID METABOLITE";"0";"436.9";"0";"4.47";"210";"CCCCc1nc(Cl)c(C(=O)O)n1Cc2ccc(cc2)c3ccccc3c4nn[nH]n4";"PPB";"";"99.78";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2312928";"";"0";"350.4";"0";"4.09";"5235";"CCCNC(c1cccnc1)P(=O)(c2ccccc2)c3ccccc3";"PPB";"";"82.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1221681";"";"0";"400.5";"0";"3.06";"5108";"O[C@@H](CN[C@H]1CCC[C@@H]1OCc2ccccc2)c3ccc(O)c4NC(=O)Sc34";"PPB";"";"82.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1353474";"";"0";"290.39";"0";"2.49";"1013";"Cc1cc(C)c(c(C)c1)S(=O)(=O)NCc2ccncc2";"PPB";"";"86.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL361812";"RAMATROBAN";"2";"416.47";"0";"3.09";"2991";"OC(=O)CCn1c2CC[C@H](Cc2c3ccccc13)NS(=O)(=O)c4ccc(F)cc4";"PPB";"";"96.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL604126";"";"0";"416.81";"0";"4.75";"5019";"Cc1cc(Oc2ncc(cc2Cl)C(F)(F)F)ccc1CC3SC(=O)NC3=O";"PPB";"";"99.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1256967";"";"0";"518.49";"2";"-1.41";"5794";"CC1(C)[C@H](NC(=O)\C(=N/OCC2=CC(=O)C(=CN2O)O)\c3csc(N)n3)C(=O)N1OS(=O)(=O)O";"PPB";"";"87.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2018964";"";"0";"505.02";"1";"4.25";"5662";"COc1cccc2c1c(NS(=O)(=O)c3ccc(Cl)s3)nn2Cc4cccc(CNC(=O)C)c4";"PPB";"";"99.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1161";"MOMETASONE FUROATE";"4";"521.44";"1";"4.87";"1821";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c5occc5)C(=O)CCl";"PPB";"";"99.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2152903";"";"0";"476.56";"0";"4.76";"5441";"CCN1C=C(C=C(C)C1=O)[C@@]2(N=C(N)c3c(F)cccc23)c4cccc(c4)c5cncc(c5)C#CC";"PPB";"";"98.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL463981";"BEGACESTAT";"1";"391.74";"0";"2.78";"5590";"OC[C@@H](NS(=O)(=O)c1ccc(Cl)s1)C(C(F)(F)F)C(F)(F)F";"PPB";"";"89.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1689109";"";"0";"424.91";"0";"2.31";"3323";"OC(=O)COc1ccc(Cl)cc1CN2CCN(CC2)S(=O)(=O)c3ccccc3";"PPB";"";"86.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2017291";"";"0";"415.45";"0";"4.16";"5890";"COc1cc2c3N([C@H](C)c4ccccn4)C(=O)Nc3cnc2cc1c5c(C)onc5C";"PPB";"";"96.26";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1938400";"PF-03715455";"2";"700.29";"2";"7.8";"5821";"CC(C)(C)c1cc(NC(=O)NCc2ccccc2Sc3ccc4nnc(c5ccccc5SCCO)n4c3)n(n1)c6ccc(O)c(Cl)c6";"PPB";"";"99.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2011123";"";"0";"484.58";"0";"3.22";"4697";"CCOc1ccc(cc1F)[C@@H](C)Nc2nc(nc3C(=O)N(Cc23)C(C)C)N4CCN(CC4)C(=O)C";"PPB";"";"74.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1254945";"";"0";"501.03";"2";"5.42";"4722";"Clc1cccc2CN(C(=O)c12)c3cccc(c3)C(=O)N4CCC5(CC4)CCN(CC5)c6ccncc6";"PPB";"";"95.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL560377";"";"0";"378.44";"1";"5.27";"4522";"C(Oc1ccc(cc1)c2n[nH]cc2c3ccncc3)c4ccc5ccccc5n4";"PPB";"";"99.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1797387";"";"0";"429.66";"1";"6.5";"1779";"Cc1onc(c1NC(=O)OCc2c(F)cccc2Cl)c3c(Cl)cccc3Cl";"PPB";"";"99.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164389";"";"0";"455.44";"0";"4.04";"4195";"FC(F)(F)Oc1ccc(CNC(=O)C2N(CCc3ccccn3)C(=O)c4ccccc24)cc1";"PPB";"";"95.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1818291";"";"0";"502.66";"2";"5.42";"4359";"CC(C)(C)OC(=O)NC[C@@H]1CC[C@@H](CNC(=O)c2cc(nc3ccccc23)c4cccc(CN)c4)CC1";"PPB";"";"98.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1213082";"";"0";"397.44";"0";"2.77";"2828";"Cc1ccccc1N2C(=Nc3cccc(C)c3C2=O)Cn4cnc5c(N)ncnc45";"PPB";"";"75.97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL421";"SULFASALAZINE";"4";"398.4";"0";"3.7";"sulfasalazine";"OC(=O)c1cc(ccc1O)\N=N\c2ccc(cc2)S(=O)(=O)Nc3ccccn3";"PPB";"";"99.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1766081";"";"0";"386.45";"0";"3.67";"4458";"CC(C)OC(=O)N1CCC(CC1)Oc2ncnc(Oc3cccnc3C)c2C";"PPB";"";"96.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1818189";"";"0";"423.56";"0";"4.81";"4032";"CC(C)(C)OC(=O)NC[C@@H]1CC[C@@H](CNC(=O)c2ccnc(c2)c3ccccc3)CC1";"PPB";"";"99.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1770297";"";"0";"423.54";"1";"5.24";"3156";"CCOc1ccc2oc(C(=O)NC(CCSC)c3nc4ccccc4[nH]3)c(C)c2c1";"PPB";"";"99.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1921942";"";"0";"476.64";"0";"4.18";"4602";"C[C@@](N1CCCCC1)(C(=O)O[C@H]2C[N+]3(CC(=O)Nc4ccccc4)CCC2CC3)c5ccccc5";"PPB";"";"98.61";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL277474";"ANTIPYRINE";"4";"188.23";"0";"1.48";"766";"CN1N(C(=O)C=C1C)c2ccccc2";"PPB";"";"29.9";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL517140";"GSK189254";"2";"351.45";"0";"3.19";"4477";"CNC(=O)c1ccc(Oc2ccc3CCN(CCc3c2)C4CCC4)nc1";"PPB";"";"47.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2152525";"";"0";"320.48";"0";"4.66";"4805";"C1CCN(C1)[C@@H]([C@H](N2CCCC2)c3ccccc3)c4ccccc4";"PPB";"";"66.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2338409";"";"0";"415.37";"0";"3.14";"5574";"CC(C)(C)NC(=O)NCCN1CCC(CNC(=O)c2cc(Cl)cc(Cl)c2)C1";"PPB";"";"86.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2325021";"";"0";"504.48";"1";"4.48";"5685";"FC(F)(F)c1ccc(Oc2ccc(cc2C#N)S(=O)(=O)Nc3ncns3)c(c1)c4ccnnc4";"PPB";"";"97.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL82663";"SIBENADET";"0";"464.61";"0";"2.9";"1566";"Oc1ccc(CCNCCS(=O)(=O)CCCOCCc2ccccc2)c3sc(O)nc13";"PPB";"";"92.16";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147569";"";"0";"449.5";"0";"4.35";"5828";"C[C@]12Cc3cnn(c3C=C1CC[C@@]2(O)CCc4ccc(F)cc4C(=O)N)c5ccc(F)cc5";"PPB";"";"99.54";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1232461";"";"0";"423.9";"0";"3.66";"5921";"CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c3cc(OC)ccc3n4c(C)nnc14";"PPB";"";"68.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1738840";"";"0";"254.29";"0";"2.15";"3168";"COc1ccnc(CCc2nc3cccnc3[nH]2)c1";"PPB";"";"69.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1807829";"";"0";"516.52";"1";"4.18";"3829";"O[C@@H](CNCCSCCCNCCc1cccc(Cl)c1Cl)c2ccc(O)c3NC(=O)Sc23";"PPB";"";"91.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1442311";"";"0";"489.6";"0";"4.3";"4786";"CN(C)C(=O)c1ccc(Nc2nnc(c3ccc(C)c(c3)S(=O)(=O)N(C)C)c4ccccc24)cc1";"PPB";"";"97.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL49";"BUSPIRONE";"4";"385.51";"0";"2.09";"295";"O=C1CC2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)c4ncccn4";"PPB";"";"75.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1503948";"";"0";"318.42";"0";"3.71";"3755";"Cc1ccc(cc1)S(=O)(=O)Nc2ccc3nc(C)sc3c2";"PPB";"";"99.47";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2338400";"";"0";"419.61";"0";"1.79";"5452";"CC(C)(C)NC(=O)NCCN1CCN(CC(=O)NC23CC4CC(CC(C4)C2)C3)CC1";"PPB";"";"69.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL841";"LOPERAMIDE";"4";"477.05";"1";"5.09";"683";"CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1683031";"";"0";"438.51";"0";"3.07";"4333";"CCOc1cc2nnc(C(=O)N)c(Nc3ccc(C)cc3F)c2cc1N4CCN(C)CC4";"PPB";"";"93.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL62";"SCH-23390";"0";"287.79";"0";"3.67";"3345";"CN1CCc2cc(Cl)c(O)cc2[C@H](C1)c3ccccc3";"PPB";"";"83.04";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL339053";"";"0";"589.18";"1";"4.56";"2632";"Clc1ccc(C[C@@H](NC(=O)[C@H]2Cc3ccccc3CN2)C(=O)N4CCC(Cn5cncn5)(CC4)C6CCCCC6)cc1";"PPB";"";"99.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL556667";"";"0";"232.67";"0";"2.99";"2335";"Clc1cccc(NC(=O)c2ccccn2)c1";"PPB";"";"95.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL31354";"WAY-100,635";"0";"422.57";"0";"3.83";"1789";"COc1ccccc1N2CCN(CCN(C(=O)C3CCCCC3)c4ccccn4)CC2";"PPB";"";"79.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2337979";"";"0";"415.37";"0";"3.29";"5576";"CC(C)(C)NC(=O)NCCN1CCCC(C1)NC(=O)c2cc(Cl)cc(Cl)c2";"PPB";"";"96.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1963249";"ULIMORELIN";"3";"538.66";"1";"2.6";"5682";"C[C@@H]1CN[C@@H](C2CC2)C(=O)N(C)[C@H](C)C(=O)N[C@H](Cc3ccc(F)cc3)C(=O)NCCCc4ccccc4O1";"PPB";"";"85.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1404";"RANOLAZINE";"4";"427.55";"0";"2.31";"2213";"COc1ccccc1OCC(O)CN2CCN(CC(=O)Nc3c(C)cccc3C)CC2";"PPB";"";"53.45";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL549";"CITALOPRAM";"4";"324.4";"0";"3.81";"717";"CN(C)CCCC1(OCc2cc(ccc12)C#N)c3ccc(F)cc3";"PPB";"";"56.3";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL19236";"MOXONIDINE";"4";"241.68";"0";"0.82";"2273";"COc1nc(C)nc(Cl)c1NC2=NCCN2";"PPB";"";"11.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL21731";"MAPROTILINE";"4";"277.41";"0";"4.21";"1372";"CNCCCC12CCC(c3ccccc13)c4ccccc24";"PPB";"";"92.16";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL193240";"ROFLUMILAST";"4";"403.21";"1";"5.03";"2902";"FC(F)Oc1ccc(cc1OCC2CC2)C(=O)Nc3c(Cl)cncc3Cl";"PPB";"";"98.86";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL10188";"TALNETANT";"2";"382.46";"1";"5.49";"1786";"CC[C@H](NC(=O)c1c(O)c(nc2ccccc12)c3ccccc3)c4ccccc4";"PPB";"";"99.95";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL219916";"DOMPERIDONE";"4";"425.92";"0";"3.35";"DOMPERIDONE";"Clc1ccc2N(C3CCN(CCCN4C(=O)Nc5ccccc45)CC3)C(=O)Nc2c1";"PPB";"";"93.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL500";"PINDOLOL";"4";"248.33";"0";"1.91";"SID50104680";"CC(C)NCC(O)COc1cccc2[nH]ccc12";"PPB";"";"41.45";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL35";"FUROSEMIDE";"4";"330.75";"0";"1.89";"FUROSEMIDE";"NS(=O)(=O)c1cc(C(=O)O)c(NCc2occc2)cc1Cl";"PPB";"";"97.95";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2103840";"DINACICLIB";"3";"396.5";"0";"2.28";"5922";"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(nc12)N4CCCC[C@H]4CCO";"PPB";"";"82.39";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL714";"ALBUTEROL";"4";"239.31";"0";"1.31";"426";"CC(C)(C)NCC(O)c1ccc(O)c(CO)c1";"PPB";"";"34.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL319111";"LINOPIRDINE";"0";"391.47";"0";"4.88";"1814";"O=C1N(c2ccccc2)c3ccccc3C1(Cc4ccncc4)Cc5ccncc5";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL275742";"DEXPROPRANOLOL";"0";"259.35";"0";"2.58";"2630";"CC(C)NC[C@@H](O)COc1cccc2ccccc12";"PPB";"";"82.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL562318";"MARDEPODECT";"2";"392.46";"1";"5.28";"4815";"Cn1cc(c2ccncc2)c(n1)c3ccc(OCc4ccc5ccccc5n4)cc3";"PPB";"";"99.83";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2316386";"";"0";"539.65";"1";"3.28";"4205";"C[S+]([O-])Cc1ccc(C(=O)Nc2ccc(OCCOCCO)nc2C(=O)NCC3CCC3)c4ccccc14";"PPB";"";"96.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL190";"THEOPHYLLINE";"4";"180.17";"0";"-1.04";"583";"CN1C(=O)N(C)c2[nH]cnc2C1=O";"PPB";"";"43.14";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1528356";"";"0";"332.45";"0";"3.74";"316";"CN(c1ccc2sc(C)nc2c1)S(=O)(=O)c3ccc(C)cc3";"PPB";"";"99.33";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1287853";"FEDRATINIB";"3";"524.69";"1";"4.82";"4876";"Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc4cccc(c4)S(=O)(=O)NC(C)(C)C";"PPB";"";"79.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL57895";"EFAROXAN";"0";"216.28";"0";"1.77";"1522";"CCC1(Cc2ccccc2O1)C3=NCCN3";"PPB";"";"24.03";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL210730";"";"0";"237.26";"0";"2.82";"499";"O=C(Nc1nc2ccccc2[nH]1)c3ccccc3";"PPB";"";"87.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2057371";"";"0";"500.59";"1";"1.61";"5670";"CC(C)(C)NS(=O)(=O)c1cncc(c1)c2ccc3nc(NC(=O)NCC(=O)N4CCCC4)nn3c2";"PPB";"";"76.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2069413";"";"0";"503.48";"1";"3.33";"4692";"OCc1ccc(cn1)c2cccc3OC[C@H](Cc23)NC(=O)c4ccc(OCCOCC(F)(F)F)nc4";"PPB";"";"91.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1944691";"";"0";"481.59";"0";"3.63";"3855";"O[C@@H](CNCCc1cccc(CNCCc2ccccc2F)c1)c3ccc(O)c4NC(=O)Sc34";"PPB";"";"86.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164371";"";"0";"434.41";"0";"3.58";"4485";"FC(F)(F)Oc1ccc(CNC(=O)C2N(C3CCOCC3)C(=O)c4ccccc24)cc1";"PPB";"";"86.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL375293";"";"0";"316.32";"0";"3.33";"5259";"N(c1cccnc1)c2ncc(c3ccncn3)c(n2)c4occc4";"PPB";"";"86.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147226";"";"0";"471.44";"0";"3.72";"5288";"COc1ncc(cn1)c2cccc(C#N)c2CCNC(=O)c3ccc(OCCC(F)(F)F)nc3";"PPB";"";"86.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179274";"";"0";"512.01";"2";"5.17";"5483";"CCC[C@H](N1CCC[C@@H](C1)N2C=C(C)C(=O)NC2=O)c3ccc(C(=O)O)c(Oc4cccc(Cl)c4)c3";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL319118";"";"0";"380.41";"0";"4.18";"1291";"COc1ccc(OC(F)(F)F)cc1CN[C@H]2CCCN[C@H]2c3ccccc3";"PPB";"";"90.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL208943";"";"0";"485.63";"0";"4.17";"3305";"O=C([C@@H]1CCCN(C1)C2CCN(CC2)C(=O)c3c4ccccc4cc5ccccc35)N6CCOCC6";"PPB";"";"73.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164044";"";"0";"476.4";"0";"3.83";"5245";"Fc1cnc(CCN2C(C(=O)NCc3ccc(F)c(c3)C(F)(F)F)c4ccccc4C2=O)nc1";"PPB";"";"87.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1939560";"";"0";"651.08";"2";"5.55";"5811";"C[C@@H](N(CC1CCS(=O)(=O)CC1)C(=O)Cc2ccc(c(F)c2)C(F)(F)F)C3=Nc4ncccc4C(=O)N3c5ccc(Cl)cc5";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2335896";"";"0";"383.46";"0";"4.63";"4511";"C[C@@H](NC(=O)C)c1ccc(Nc2ncc3cc(ccc3n2)c4ccncc4)cc1";"PPB";"";"94.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2058631";"";"0";"244.13";"0";"2.75";"1762";"CC1CNC(=N1)Nc2c(Cl)cccc2Cl";"PPB";"";"35.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2087421";"";"0";"496.67";"0";"1.19";"5768";"COc1cc(C)c(c(C)c1)S(=O)(=O)N(C)CCOCC(=O)N2CCN(CC2)C3CCN(C)CC3";"PPB";"";"37.06";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1113";"AMOXAPINE";"4";"313.79";"0";"3.43";"1518";"Clc1ccc2Oc3ccccc3N=C(N4CCNCC4)c2c1";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1231206";"";"0";"374.47";"0";"4.36";"5382";"C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)c5ccc(C)nc5)C(=O)N1";"PPB";"";"98.86";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL129198";"JNJ-7777120";"0";"277.76";"0";"2.21";"2365";"CN1CCN(CC1)C(=O)c2cc3cc(Cl)ccc3[nH]2";"PPB";"";"77.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2021696";"";"0";"654.6";"3";"-2.9";"5807";"CN1C(=O)N(N=C1C2=CC(=O)C(=CN2)O)S(=O)(=O)NC(=O)N3C[C@H](NC(=O)\C(=N/OC(C)(C)C(=O)O)\c4csc(N)n4)C3=O";"PPB";"";"98.51";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL453";"SULFISOXAZOLE";"4";"267.31";"0";"1.67";"99";"Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C";"PPB";"";"98.47";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2324355";"";"0";"378.31";"0";"3.78";"5635";"Cc1nocc1C(=O)Nc2ccc(c(N)n2)c3ccccc3OC(F)(F)F";"PPB";"";"96.34";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL95804";"SEMATILIDE";"0";"313.42";"0";"1.13";"559";"CCN(CC)CCNC(=O)c1ccc(NS(=O)(=O)C)cc1";"PPB";"";"10.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL331372";"CGS-21680";"0";"499.53";"2";"-0.16";"2, CGS21680";"CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(N)nc(NCCc4ccc(CCC(=O)O)cc4)nc23";"PPB";"";"89.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL957";"BOSENTAN";"4";"551.63";"1";"4.2";"707";"COc1ccccc1Oc2c(NS(=O)(=O)c3ccc(cc3)C(C)(C)C)nc(nc2OCCO)c4ncccn4";"PPB";"";"98.78";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2059859";"";"0";"434.5";"1";"5.76";"4456";"Cc1ccc(cc1NC(=O)c2ccc(OCc3ccccn3)cc2)c4nc5ccccc5[nH]4";"PPB";"";"94.68";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2017459";"";"0";"409.92";"0";"4.68";"5760";"CCN(C(=O)c1oc(cc1)c2ccc(Cl)cc2)c3ccc(cc3)N4CCNCC4";"PPB";"";"95.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2088414";"";"0";"399.29";"0";"3.35";"3134";"OCc1nc2cc(NS(=O)(=O)c3ccc(Br)cc3)ccc2s1";"PPB";"";"99.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2169920";"";"0";"577.55";"1";"4.55";"4647";"Oc1ccc(CCNCCN(C2CCCCC2)C(=O)CCNCCc3ccc(Cl)c(Cl)c3)c4OCC(=O)Nc14";"PPB";"";"91.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147309";"";"0";"466.41";"0";"4.18";"5442";"Cc1cnc(cn1)c2c(F)ccc(F)c2CCNC(=O)c3ccc(COCC(F)(F)F)nc3";"PPB";"";"71.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2151320";"";"0";"338.35";"0";"2.55";"4022";"C[C@H](Nc1ccc2ncn(c3cc(C)[nH]n3)c2n1)c4ncc(F)cn4";"PPB";"";"51.73";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916288";"";"0";"483.57";"0";"4.16";"5188";"C[C@H](NC(=O)c1c(C)nn(c1NS(=O)(=O)c2ccc(cc2)C#N)c3ccc(F)cc3)C(C)(C)C";"PPB";"";"91.99";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL513389";"ICI-118551";"0";"277.41";"0";"2.61";"1760";"CC(C)NC(C)C(O)COc1ccc(C)c2CCCc12";"PPB";"";"78.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2069403";"";"0";"432.53";"0";"2.06";"4255";"CN1CCN(CC1)c2cccc3OC[C@H](Cc23)NC(=O)c4nn(nc4C)c5ccccc5";"PPB";"";"96.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158441";"";"0";"355.23";"0";"2.53";"5081";"Clc1cccc(Cl)c1CNC2=NC(=CC(=O)N2)N3CCOCC3";"PPB";"";"95.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1916282";"";"0";"454.6";"0";"4.45";"5087";"C[C@H](NC(=O)c1c(C)nn(c1NS(=O)(=O)c2ccc(C)cc2)c3ccccc3)C(C)(C)C";"PPB";"";"95.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2165177";"";"0";"350.42";"0";"2.4";"4994";"CN(Cc1cccc2ccccc12)C3=CC(=NC(=O)N3)N4CCOCC4";"PPB";"";"99.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL502";"DONEPEZIL";"4";"379.5";"0";"4.36";"430";"COc1cc2CC(CC3CCN(Cc4ccccc4)CC3)C(=O)c2cc1OC";"PPB";"";"66.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL569184";"";"0";"419.5";"0";"2.19";"5567";"COc1ccc(CCN2[C@H](CN(NS(=O)(=O)C)C2=O)c3ccc(OC)cc3)cc1";"PPB";"";"98.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1172";"DESLORATADINE";"4";"310.83";"0";"4.02";"1721";"Clc1ccc2C(=C3CCNCC3)c4ncccc4CCc2c1";"PPB";"";"85.48";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL372205";"LECOZOTAN";"3";"483.57";"0";"3.58";"4330";"C[C@H](CN(C(=O)c1ccc(cc1)C#N)c2ccccn2)N3CCN(CC3)c4cccc5OCCOc45";"PPB";"";"82.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL255044";"FLUPIRTINE";"2";"304.32";"0";"2.98";"694";"CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N";"PPB";"";"78.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1294";"QUINIDINE";"4";"324.42";"0";"3.17";"Quinidine";"COc1ccc2nccc([C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1";"PPB";"";"60.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL642";"ACEBUTOLOL";"4";"336.43";"0";"2.37";"Acebutolol";"CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(c1)C(=O)C";"PPB";"";"28.95";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL41";"FLUOXETINE";"4";"309.33";"0";"4.44";"SID90341619";"CNCCC(Oc1ccc(cc1)C(F)(F)F)c2ccccc2";"PPB";"";"94.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL279898";"ENPROFYLLINE";"0";"194.19";"0";"-0.18";"SID50104067";"CCCN1C(=O)NC(=O)c2[nH]cnc12";"PPB";"";"78.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL723";"CARVEDILOL";"4";"406.48";"0";"3.74";"1768";"COc1ccccc1OCCNCC(O)COc2cccc3[nH]c4ccccc4c23";"PPB";"";"97.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL669";"CYCLOBENZAPRINE";"4";"275.4";"0";"4.55";"1385";"CN(C)CCC=C1c2ccccc2C=Cc3ccccc13";"PPB";"";"88.35";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1090771";"AVAGACESTAT";"2";"520.89";"1";"3.92";"5401";"NC(=O)[C@@H](CCC(F)(F)F)N(Cc1ccc(cc1F)c2nocn2)S(=O)(=O)c3ccc(Cl)cc3";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL165790";"IPRIFLAVONE";"0";"280.32";"0";"4.25";"IPRIFLAVONE";"CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3";"PPB";"";"99.44";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1144";"PRAVASTATIN";"4";"424.53";"0";"2.44";"577";"CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@@H]12";"PPB";"";"65.06";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL538936";"";"0";"568.59";"2";"6.68";"3351";"Fc1ccc(cc1)C(NC(=O)CC2CCN(Cc3ccn(c3)c4ccc(cn4)C(F)(F)F)CC2)c5ccc(F)cc5";"PPB";"";"99.67";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1515";"METHIMAZOLE";"4";"114.17";"0";"1.08";"Methimazole";"CN1C=CNC1=S";"PPB";"";"18.64";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL11";"IMIPRAMINE";"4";"280.42";"0";"3.88";"490";"CN(C)CCCN1c2ccccc2CCc3ccccc13";"PPB";"";"82.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1509029";"";"0";"332.45";"0";"4.02";"3762";"Cc1ccc(cc1C)S(=O)(=O)Nc2ccc3nc(C)sc3c2";"PPB";"";"99.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1800807";"ANACETRAPIB";"3";"637.51";"2";"9.76";"5689";"COc1cc(F)c(cc1c2ccc(cc2CN3[C@@H](C)[C@H](OC3=O)c4cc(cc(c4)C(F)(F)F)C(F)(F)F)C(F)(F)F)C(C)C";"PPB";"";"96.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1539841";"";"0";"362.43";"0";"3.18";"3754";"Cc1nc2ccc(NS(=O)(=O)c3ccc4OCCOc4c3)cc2s1";"PPB";"";"99.33";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL184";"ACYCLOVIR";"4";"225.21";"0";"-0.92";"Acyclovir";"Nc1nc(O)c2ncn(COCCO)c2n1";"PPB";"";"10.09";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164043";"";"0";"492.4";"0";"3.71";"5305";"Fc1cnc(CCN2C(C(=O)NCc3ccc(F)c(OC(F)(F)F)c3)c4ccccc4C2=O)nc1";"PPB";"";"90.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1164033";"SB611812";"0";"491.75";"1";"5.41";"5916";"CN(C)CCOc1cc(NS(=O)(=O)c2c(Cl)cc(cc2Cl)C(F)(F)F)ccc1Cl";"PPB";"";"99.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2147307";"";"0";"478.45";"0";"4.05";"5428";"COc1cnc(cn1)c2c(C)ccc(F)c2CCNC(=O)c3ccc(COCC(F)(F)F)nc3";"PPB";"";"90.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2316382";"";"0";"495.6";"0";"3.53";"3934";"COc1ccc(NC(=O)c2ccc(C[S+](C)[O-])c3ccccc23)c(n1)C(=O)NCC4CCOCC4";"PPB";"";"95.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL178737";"";"0";"496.53";"0";"2.12";"SID174007010";"O=C(N1CCOCC1)N2CCn3cc(C4=C(C(=O)NC4=O)c5cnc6ccccn56)c7cccc(C2)c37";"PPB";"";"88.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1289283";"";"0";"414.51";"0";"3.86";"5633";"O=C1C=C(OCc2ccccc2)C=CN1c3ccc4c(cnn4CCN5CCCC5)c3";"PPB";"";"88.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL16";"PHENYTOIN";"4";"252.27";"0";"1.97";"782";"OC1=NC(=O)C(N1)(c2ccccc2)c3ccccc3";"PPB";"";"82.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL621";"TRAZODONE";"4";"371.87";"0";"2.36";"405";"Clc1cccc(c1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2";"PPB";"";"87.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL355832";"";"0";"295.37";"0";"4.45";"1631";"O=C(Nc1ccccc1)Nc2nc(cs2)c3ccccc3";"PPB";"";"99.95";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL396298";"ELACRIDAR";"0";"563.65";"2";"5.56";"3115";"COc1cccc2C(=O)c3cccc(C(=O)Nc4ccc(CCN5CCc6cc(OC)c(OC)cc6C5)cc4)c3Nc12";"PPB";"";"98.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL655";"MIDAZOLAM";"4";"325.77";"0";"4.32";"1215";"Cc1ncc2CN=C(c3ccccc3F)c4cc(Cl)ccc4n12";"PPB";"";"95.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL428768";"(S)-FELODIPINE";"0";"384.26";"0";"3.96";"3029";"CCOC(=O)C1=C(C)NC(=C([C@@H]1c2cccc(Cl)c2Cl)C(=O)OC)C";"PPB";"";"99.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2165066";"";"0";"476.51";"0";"1.8";"4478";"F[C@H]1CN(CCN2C(=O)C=Cc3ccc(cc23)C#N)CC[C@H]1NCc4ccc5OCC(=O)Nc5n4";"PPB";"";"71.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL589973";"";"0";"581.47";"2";"5.75";"3362";"CCCCNC(=O)c1ccc(Oc2ccc(CC(=O)O)cc2OC)c(NS(=O)(=O)c3ccc(Cl)cc3Cl)c1";"PPB";"";"99.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1797410";"";"0";"474.27";"1";"5.15";"4626";"Cc1onc(c1CC(=O)NCc2ccc(OCC(F)(F)F)nc2)c3c(Cl)cccc3Cl";"PPB";"";"95.43";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL560423";"";"0";"392.84";"0";"1.39";"3338";"OC1(CNC(=O)c2cc(ccc2Cl)N3N=CC(=O)NC3=O)CCCCCC1";"PPB";"";"87.11";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL383322";"RESIQUIMOD";"2";"314.39";"0";"2.47";"1653";"CCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)O";"PPB";"";"42.57";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2144069";"";"0";"451.53";"1";"5.04";"3241";"CN1C=Nc2ccc(Nc3cc(NC(=O)c4cccc(c4)C(C)(C)C#N)ccc3C)cc2C1=O";"PPB";"";"50";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2158785";"";"0";"514.04";"1";"4.91";"3425";"Cc1c(Cl)c(ccc1OC2CCN(CC3CCN(CC3)[C@@H](Cc4ccc(F)cc4)C(=O)O)CC2)C#N";"PPB";"";"52.3";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL570015";"";"0";"518.6";"1";"3.93";"5161";"COc1cccc(Nc2c(cnc3c(C)cc(cc23)S(=O)(=O)c4cccc(c4)C(=O)N(C)C)C(=O)N)c1";"PPB";"";"97.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1086310";"";"0";"355.4";"0";"1.2";"4925";"CC(C)c1ccc(NC(=O)Cn2cnc3N(C)C(=O)N(C)C(=O)c23)cc1";"PPB";"";"87.62";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2177736";"";"0";"393.45";"0";"1.58";"5728";"N[C@H]1CCCC[C@H]1Nc2ncc(C(=O)N)c(Nc3cccc(c3)n4nccn4)n2";"PPB";"";"91.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2165189";"";"0";"394.48";"0";"2.15";"5282";"C[C@H]1CN(CCO1)C2=NC(=O)NC(=C2)N(CCO)Cc3cccc4ccccc34";"PPB";"";"90.52";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2179277";"";"0";"584.51";"2";"5.91";"5629";"CC1=CN([C@H]2CCCN(C2)[C@H](CC(C)(C)C)c3ccc(C(=O)O)c(Oc4cccc(Br)c4)c3)C(=O)NC1=O";"PPB";"";"98.51";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL445";"NORTRIPTYLINE";"4";"263.38";"0";"3.83";"429";"CNCCC=C1c2ccccc2CCc3ccccc13";"PPB";"";"86.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL726";"FLUPHENAZINE";"4";"437.53";"0";"4.31";"472";"OCCN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1";"PPB";"";"98.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL205627";"";"0";"464.52";"0";"4.46";"2427";"COC[C@H](C)Oc1cc(O[C@@H](C)Cc2ccccc2)cc(c1)C(=O)Nc3ccc(cn3)C(=O)O";"PPB";"";"99.58";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1628227";"DOXEPIN";"4";"279.38";"0";"3.96";"2999";"CN(C)CCC=C1c2ccccc2COc3ccccc13";"PPB";"";"79.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1957460";"";"0";"372.82";"0";"4.9";"4927";"Cc1nccc(c1Cl)c2ccc(cc2)c3nc4ccncc4c(O)c3C#N";"PPB";"";"99.86";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1334692";"LONAZOLAC";"0";"312.76";"0";"3.82";"5085";"OC(=O)Cc1cn(nc1c2ccc(Cl)cc2)c3ccccc3";"PPB";"";"99.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL41355";"EZOGABINE";"4";"303.34";"0";"3.59";"1298";"CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N";"PPB";"";"79.92";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL809";"SERTRALINE";"4";"306.24";"1";"5.18";"1847";"CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c3ccccc13";"PPB";"";"98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1277809";"";"0";"339.4";"0";"4.23";"1688";"O=C(NCc1ccccn1)c2cc(nc3ccccc23)c4ccccc4";"PPB";"";"98";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1945292";"";"0";"417.53";"0";"1.9";"3909";"COCCNCc1cccc(CCNC[C@H](O)c2ccc(O)c3NC(=O)Sc23)c1";"PPB";"";"80.29";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL569185";"";"0";"419.5";"0";"2.19";"5538";"COc1ccc(CCN2[C@@H](CN(NS(=O)(=O)C)C2=O)c3ccc(OC)cc3)cc1";"PPB";"";"94.32";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1463345";"CANRENONE";"4";"340.46";"0";"4.37";"4162";"C[C@]12CCC(=O)C=C1C=C[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CC[C@@]45CCC(=O)O5";"PPB";"";"96.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL526307";"";"0";"400.22";"0";"3.17";"4685";"COc1cc(C(C)C)c(Oc2cnc(N)nc2N)cc1I";"PPB";"";"96.17";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1270208";"";"0";"421.81";"0";"4.67";"5714";"FC(F)(F)COc1ncccc1CNC(=O)c2cncc(c2)c3ccc(Cl)cc3";"PPB";"";"99.87";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1813048";"";"0";"516.52";"1";"4.97";"5771";"CC(=O)Nc1cccc(Nc2ncnc(n2)N3CCC(CC3)OCc4ccc(OC(F)(F)F)cc4)c1C";"PPB";"";"99.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1352569";"";"0";"359.86";"0";"3.24";"2729";"CC(C)(Oc1ccc(Cl)cc1)C(=O)N2CCN(CC2)c3ccccn3";"PPB";"";"99.08";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1818300";"";"0";"579.79";"1";"4.58";"4863";"CC(C)(C)OC(=O)NC[C@@H]1CC[C@@H](CNC(=O)c2cc(nc3ccccc23)N4CCC(CCN5CC(O)C5)CC4)CC1";"PPB";"";"96.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL456324";"";"0";"479.94";"1";"3.46";"3347";"CC(C)Oc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cc3)nc(NC(CO)CO)c2Cl)n[nH]1";"PPB";"";"95.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL14762";"SELICICLIB";"2";"354.46";"0";"3.2";"Roscovitine";"CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1";"PPB";"";"92.8";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1580912";"";"0";"260.72";"0";"2.71";"2835";"Clc1ccc(CCNC(=O)c2cccnc2)cc1";"PPB";"";"91.46";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL163";"RITONAVIR";"4";"720.96";"2";"5.91";"RTV";"CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc3cncs3)Cc4ccccc4";"PPB";"";"96.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1957266";"";"0";"457";"1";"5.53";"1; (+)-JQ1";"Cc1sc2c(C(=N[C@@H](CC(=O)OC(C)(C)C)c3nnc(C)n23)c4ccc(Cl)cc4)c1C";"PPB";"";"98.47";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1738797";"ALECTINIB";"4";"482.63";"0";"4.77";"5725";"CCc1cc2C(=O)c3c([nH]c4cc(ccc34)C#N)C(C)(C)c2cc1N5CCC(CC5)N6CCOCC6";"PPB";"";"50";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL72";"DESIPRAMINE";"4";"266.39";"0";"3.53";"DESIPRAMINE";"CNCCCN1c2ccccc2CCc3ccccc13";"PPB";"";"81.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2107366";"REZATOMIDINE";"0";"232.35";"0";"3.84";"5754";"C[C@H](C1=CNC(=S)N1)c2cccc(C)c2C";"PPB";"";"81.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1496905";"";"0";"325.32";"0";"2.06";"4779";"COc1ccc2N(CC3COc4ccccc4O3)C(=O)C(=O)c2c1";"PPB";"";"99.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1297";"FENOPROFEN";"4";"242.27";"0";"3.67";"780";"CC(C(=O)O)c1cccc(Oc2ccccc2)c1";"PPB";"";"98.54";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL452861";"(-)-PROPANOLOL ";"0";"259.35";"0";"2.58";"2631";"CC(C)NC[C@H](O)COc1cccc2ccccc12";"PPB";"";"79.55";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1817676";"";"0";"551.78";"2";"5.46";"5274";"CN(C)CCC1CCN(CC1)c2cc(C(=O)NC[C@@H]3CC[C@@H](COC(=O)NC(C)(C)C)CC3)c4ccccc4n2";"PPB";"";"96.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1240967";"";"0";"617.77";"2";"4.64";"5293";"CC(C)(Cc1cccc(CC(=O)NCc2cccc(c2)c3ccc(O)cc3)c1)NC[C@H](O)c4ccc(O)c(NS(=O)(=O)C)c4";"PPB";"";"91.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1972466";"";"0";"364.45";"0";"3.01";"3706";"CC(Nc1ccccc1)C2=CC(=CN3C(=O)C=C(N=C23)N4CCOCC4)C";"PPB";"";"95.33";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1072";"BUMETANIDE";"4";"364.42";"0";"3.04";"1506";"CCCCNc1cc(cc(c1Oc2ccccc2)S(=O)(=O)N)C(=O)O";"PPB";"";"96.34";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1346";"DARIFENACIN";"4";"426.56";"0";"3.96";"3453";"NC(=O)C([C@@H]1CCN(CCc2ccc3OCCc3c2)C1)(c4ccccc4)c5ccccc5";"PPB";"";"92.16";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2164360";"";"0";"469.46";"0";"4.42";"4600";"CC(Cc1ccccn1)N2C(C(=O)NCc3ccc(OC(F)(F)F)cc3)c4ccccc4C2=O";"PPB";"";"96.34";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1614705";"";"0";"415.86";"0";"3.02";"4945";"OCC(=O)N1CCC(CC1)c2[nH]nc(c3ccc(Cl)cc3F)c2c4ccncn4";"PPB";"";"67.63";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1770298";"";"0";"394.5";"0";"4.49";"1672";"Cc1ccc(s1)C(NC(=O)c2ccccc2O)C(=O)Nc3c(C)cccc3C";"PPB";"";"99.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1929039";"";"0";"391.32";"0";"4.34";"5819";"Cc1cc(F)ccc1n2nc(cc2c3ccc4OCC(=O)Nc4c3)C(F)(F)F";"PPB";"";"81.01";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1945044";"";"0";"479.6";"0";"3.46";"4053";"COc1cccc(CNCc2cccc(CCNC[C@H](O)c3ccc(O)c4NC(=O)Sc34)c2)c1";"PPB";"";"84.6";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL552512";"";"0";"367.49";"0";"3.83";"4755";"O=C(CC1CCCCCC1)Nc2cccc3C(=O)N(C=Cc23)[C@H]4CCNC4";"PPB";"";"76.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL914";"FEXOFENADINE";"4";"501.67";"2";"5.51";"2145";"CC(C)(C(=O)O)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4";"PPB";"";"76.81";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL126";"LINEZOLID";"4";"337.35";"0";"1.12";"Linezolid";"CC(=O)NC[C@H]1CN(C(=O)O1)c2ccc(N3CCOCC3)c(F)c2";"PPB";"";"22.38";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL573";"NIACIN";"4";"123.11";"0";"0.78";"Nicotinic acid";"OC(=O)c1cccnc1";"PPB";"";"45.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL741";"LAMOTRIGINE";"4";"256.1";"0";"2.01";"SID855818";"Nc1nnc(c(N)n1)c2cccc(Cl)c2Cl";"PPB";"";"48.85";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1423";"PIMOZIDE";"4";"461.56";"1";"5.86";"469";"Fc1ccc(cc1)C(CCCN2CCC(CC2)N3C(=O)Nc4ccccc34)c5ccc(F)cc5";"PPB";"";"99.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL558";"MEXILETINE";"4";"179.26";"0";"2.03";"1369";"CC(N)COc1c(C)cccc1C";"PPB";"";"36.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1734492";"";"0";"309.37";"0";"2.52";"5880";"NC(=O)NC(=O)C(Nc1ccc2CCCc2c1)c3ccccc3";"PPB";"";"94.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1471";"APREPITANT";"4";"534.43";"1";"4.95";"2535";"C[C@@H](O[C@H]1OCCN(CC2=NNC(=O)N2)[C@H]1c3ccc(F)cc3)c4cc(cc(c4)C(F)(F)F)C(F)(F)F";"PPB";"";"99.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL216981";"NAVARIXIN";"2";"397.43";"0";"2.9";"4044";"CC[C@@H](NC1=C(Nc2cccc(C(=O)N(C)C)c2O)C(=O)C1=O)c3oc(C)cc3";"PPB";"";"98.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL110999";"";"0";"430.57";"0";"3.85";"1879";"CN(CCCOCCOCCc1ccccc1)CCc2ccc(O)c3nc(O)sc23";"PPB";"";"75.97";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL832";"SULFINPYRAZONE";"4";"404.49";"0";"3.8";"2940";"[O-][S+](CCC1C(=O)N(N(C1=O)c2ccccc2)c3ccccc3)c4ccccc4";"PPB";"";"99.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL6966";"VERAPAMIL";"4";"454.61";"1";"5.09";"Verapamil";"COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC";"PPB";"";"86.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL81";"RALOXIFENE";"4";"473.59";"1";"6.08";"SID11111734";"Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4";"PPB";"";"99.5";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL114";"SAQUINAVIR";"4";"670.86";"1";"3.09";"SQV";"CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)[C@H](CC(=O)N)NC(=O)c4ccc5ccccc5n4";"PPB";"";"99.52";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL708";"ZIPRASIDONE";"4";"412.95";"0";"3.81";"1138";"Clc1cc2NC(=O)Cc2cc1CCN3CCN(CC3)c4nsc5ccccc45";"PPB";"";"99.7";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1073";"GLIPIZIDE";"4";"445.55";"0";"2.08";"GLIPIZIDE";"Cc1cnc(cn1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3";"PPB";"";"97.76";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1464";"WARFARIN";"4";"308.33";"0";"3.61";"W";"CC(=O)CC(C1=C(O)c2ccccc2OC1=O)c3ccccc3";"PPB";"";"99.21";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL8";"CIPROFLOXACIN";"4";"331.35";"0";"1.58";"Ciprofloxacin";"OC(=O)C1=CN(C2CC2)c3cc(N4CCNCC4)c(F)cc3C1=O";"PPB";"";"43.14";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL108";"CARBAMAZEPINE";"4";"236.27";"0";"3.39";"CARBAMAZEPINE";"NC(=O)N1c2ccccc2C=Cc3ccccc13";"PPB";"";"73.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL475534";"NITRENDIPINE";"4";"360.37";"0";"2.57";"564";"CCOC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OC)C";"PPB";"";"99.23";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1789941";"RUXOLITINIB";"4";"306.37";"0";"3.47";"4675";"N#CC[C@H](C1CCCC1)n2cc(cn2)c3ncnc4[nH]ccc34";"PPB";"";"82.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1282";"IMIQUIMOD";"4";"240.31";"0";"2.82";"4110";"CC(C)Cn1cnc2c(N)nc3ccccc3c12";"PPB";"";"82.05";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1672";"CEFPODOXIME";"0";"427.46";"0";"-0.54";"5856";"COCC1=C(N2[C@H](SC1)[C@H](NC(=O)\C(=N/OC)\c3csc(N)n3)C2=O)C(=O)O";"PPB";"";"54.59";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1363";"ARFORMOTEROL";"4";"344.41";"0";"2.22";"1800";"COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1";"PPB";"";"60.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL643";"PROMETHAZINE";"4";"284.43";"0";"4.24";"117";"CC(CN1c2ccccc2Sc3ccccc13)N(C)C";"PPB";"";"92.95";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1078411";"";"0";"311.41";"0";"2.18";"5079";"N[C@@H](Cc1cccs1)C(=O)N[C@@]2(C[C@@H]2c3ccccc3)C#N";"PPB";"";"65.58";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL304858";"";"0";"448.38";"1";"5.88";"5914";"CN(CCCCCCOc1ccc(C(=O)c2ccc(Br)cc2)c(F)c1)CC=C";"PPB";"";"99.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL631";"PROPAFENONE";"4";"341.45";"0";"3.24";"1517";"CCCNCC(O)COc1ccccc1C(=O)CCc2ccccc2";"PPB";"";"95.91";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL42";"CLOZAPINE";"4";"326.83";"0";"3.72";"CLOZAPINE";"CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24";"PPB";"";"93.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL384467";"DEXAMETHASONE";"4";"392.47";"0";"1.9";"1";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"PPB";"";"87.37";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL158";"AZTREONAM";"4";"435.44";"0";"-1.17";"1";"C[C@H]1[C@H](NC(=O)\C(=N/OC(C)(C)C(=O)O)\c2csc(N)n2)C(=O)N1S(=O)(=O)O";"PPB";"";"81.71";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1483";"ALBENDAZOLE";"4";"265.34";"0";"3.24";"SID170464897";"CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1";"PPB";"";"94.19";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL567";"PERPHENAZINE";"4";"403.98";"0";"3.94";"444";"OCCN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1";"PPB";"";"98.54";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL85";"RISPERIDONE";"4";"410.49";"0";"3.59";"1057";"CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1";"PPB";"";"94.56";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL63";"ROLIPRAM";"2";"275.35";"0";"2.62";"1, Rolipram";"COc1ccc(cc1OC2CCCC2)C3CNC(=O)C3";"PPB";"";"67.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL108922";"";"0";"368.48";"0";"3.84";"4, BTA 188";"CCO\N=C\c1ccc(OCCC2CCN(CC2)c3ccc(C)nn3)cc1";"PPB";"";"99.66";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL192";"SILDENAFIL";"4";"474.59";"0";"1.61";"Sildenafil";"CCCc1nn(C)c2C(=O)NC(=Nc12)c3cc(ccc3OCC)S(=O)(=O)N4CCN(C)CC4";"PPB";"";"90.12";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL49247";"";"0";"336.44";"0";"2.75";"4349";"C1COc2c(O1)cccc2N3CCN(CC3)C4Cc5ccccc5C4";"PPB";"";"95.72";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL193";"NIFEDIPINE";"4";"346.34";"0";"2.18";"nifedipine";"COC(=O)C1=C(C)NC(=C(C1c2ccccc2[N+](=O)[O-])C(=O)OC)C";"PPB";"";"99.77";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL511115";"CILOMILAST";"3";"343.42";"0";"4.05";"2664";"COc1ccc(cc1OC2CCCC2)[C@@]3(CC[C@H](CC3)C(=O)O)C#N";"PPB";"";"93.94";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL2";"PRAZOSIN";"4";"383.41";"0";"1.78";"PRAZOSIN";"COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)c4occc4";"PPB";"";"78.41";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL1428";"NIMODIPINE";"4";"418.45";"0";"2.97";"NIMODIPINE";"COCCOC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OC(C)C)C";"PPB";"";"98.25";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL898";"DIFLUNISAL";"4";"250.2";"0";"3.04";"DIFLUNISAL";"OC(=O)c1cc(ccc1O)c2ccc(F)cc2F";"PPB";"";"99.82";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL601719";"CRIZOTINIB";"4";"450.35";"1";"5.04";"Crizotinib";"C[C@@H](Oc1cc(cnc1N)c2cnn(c2)C3CCNCC3)c4c(Cl)ccc(F)c4Cl";"PPB";"";"95.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL422";"TRIFLUOPERAZINE";"4";"407.51";"0";"4.95";"trifluoperazine";"CN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1";"PPB";"";"99.3";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL36";"PYRIMETHAMINE";"4";"248.72";"0";"2.52";"32 (tableIII)";"CCc1nc(N)nc(N)c1c2ccc(Cl)cc2";"PPB";"";"93.1";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL479";"THIORIDAZINE";"4";"370.59";"1";"5.89";"7";"CSc1ccc2Sc3ccccc3N(CCC4CCCCN4C)c2c1";"PPB";"";"99.3";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL115";"INDINAVIR";"4";"613.8";"1";"2.87";"INDINAVIR";"CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc3ccccc3)C(=O)N[C@@H]4[C@H](O)Cc5ccccc45";"PPB";"";"78.79";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL412142";"CHIR-99021";"0";"465.35";"0";"4.94";"4644";"Cc1c[nH]c(n1)c2cnc(NCCNc3ccc(cn3)C#N)nc2c4ccc(Cl)cc4Cl";"PPB";"";"95.53";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL54";"HALOPERIDOL";"4";"375.87";"0";"4.43";"haloperidol";"OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3";"PPB";"";"81.36";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL32";"MOXIFLOXACIN";"4";"401.44";"0";"2.37";"MXFX";"COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc4C(=O)C(=CN(C5CC5)c14)C(=O)O";"PPB";"";"34.42";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
"CHEMBL941";"IMATINIB";"4";"493.62";"0";"4.59";"IMATINIB";"CN1CCN(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)CC1";"PPB";"";"97.2";"%";"";"";"";"UO_0000187";"";"";"";"";"False";"CHEMBL3301366";"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.";"A";"BAO_0000366";"cell-free format";"Rattus norvegicus";"CHEMBL3559721";"Plasma";"";"";"CHEMBL612558";"ADMET";"";"ADMET";"CHEMBL3301361";"27";"AstraZeneca Deposited Data";"";"";""
